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Since June of 2013, Plan B and its generics have been available over-the-counter
without age restriction nationwide. Even so, pharmacy-based economic, physical, and
staff-associated barriers still exist, potentially leading adolescent customers to fail to
obtain emergency contraception (EC) in a sufficiently timely manner to prevent
pregnancy. This study explores these pharmacy-based barriers to EC in the state of
Kentucky focusing on comparisons of urban and non-urban pharmacies and chain and
private pharmacies. Using a secret-shopper survey technique, the researcher called 220
Kentucky pharmacies acting as a 15-year-old girl seeking information about EC. Among
other findings, a logistic regression analysis revealed that private pharmacies were 97%
less likely to carry EC compared to chain pharmacies (OR= .027; p<.001). Linear
regression analyses found that urban pharmacies scored higher on EC knowledge (β=
.608; p<.05) and lower on negative attitude (β= -.622; p<.01) than rural pharmacies. This
research reveals that rural Kentucky adolescents face more barriers when seeking EC
than urban teens. It also demonstrates that whether a pharmacy is a chain or privatelyoperated is a better predictor of whether it will carry over-the-counter EC than urban or
rural location alone. Further, it supports the argument for more pharmacy-staff training to
effectively counsel those seeking EC and for better promotion of the EC and other family
planning resources available through the public health system.
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Chapter 1
INTRODUCTION TO THE STUDY
Nearly half of all pregnancies in the United States are unintended (Guttmacher
Institute, 2016a). Women with unintended pregnancies are more likely to have less access
to prenatal care and to experience adverse health outcomes including low birth weight,
developmental delays, and infant and maternal mortality (Dehlendorf, Rodriguez, Levy,
Borrero, & Steinauer, 2010). These problems are compounded for adolescent mothers
who often forgo educational and occupational opportunities, contributing to even further
disparities of opportunity for their children (Dehlendorf, et al., 2010). The 2010 U.S.
Census shows that 68% of unplanned births were paid for by public health programs,
especially Medicaid (Guttmacher Institute, 2016a). In response to these outcomes, the
U.S. Department of Health and Human Services’ Healthy People 2020 plan aims to lower
unintended pregnancy by 10% by 2020 (HHS, 2014). To achieve this goal, it is necessary
to understand factors contributing to unintended pregnancy. Among these factors is the
availability of emergency contraception to women in general and to adolescents in
particular.
More than four out of five pregnancies among American females aged 19 and
younger are unintended and nearly all (98%) pregnancies among teens younger than 15
are reported as unintended (Finer & Zolna, 2011). In the United States overall, the 2011
birth rate for adolescents aged 15-17 years was 15.4 per thousand, while the rate for
Kentucky teens aged 15-17 years was 19.6 per thousand (HHS, 2016). The U.S. teen
birth rate fell by 49% from 1991 to 2011, while the Kentucky teen birth rate fell by only

1

37% over the same period (HHS, 2016). In 2008, 64% unintended pregnancies in
Kentucky were described as mistimed, but 36% were described as “unwanted,” a number
lower only than New York State at 37% (Kost, 2015). Even so, the percentage of
unintended pregnancies in Kentucky ending in abortion was 20%, one of the lowest in the
nation (Kost, 2015).
Lower educational attainment and lower socio-economic status are correlated to
higher rates of unintended pregnancy. In 2011, the rate of unintended pregnancy for
women below the federal poverty level was nearly seven times higher than for women at
200% of the federal poverty level or higher (Guttmacher Institute, 2016a). Furthermore,
women without a high school degree had the highest rate of unintended pregnancy; this
rate decreased with every additional year of education attained (Guttmacher Institute,
2016a). Many women report gaps in contraceptive usage due to life-events which disrupt
their routines. These events include moving to a new home, changes in employment or
relationship status, or life crises. Such transitional life events are more common for
women in lower socio-economic living conditions or with lower educational attainment
(Frost, 2011).
Similarly, women of color also have higher rates of unintended pregnancy. Recent
surveys indicate that about 69% of Black women’s pregnancies were unplanned and 54%
of Hispanic women’s pregnancies were unplanned, compared to 40% of White women’s
pregnancies reported as unplanned (Dehlendorf, et al., 2010). Additionally, Hispanic
women, especially recent immigrants with limited English language skills, have be less
knowledge than do White women of the varieties of and proper use of available
contraceptives (Craig, Dehlendorf, Borrero, Harper, & Rocca, 2014).
2

The problems these at-risk population groups experience in accessing
contraception are amplified for adolescent females who share similar demographic
characteristics (Dehlendorf, et al., 2010). Adolescents will likely face the same barriers to
EC access that adult women do, though these are compounded. For example, adult
women may need to pay for contraceptives and travel to a health care provider or a
pharmacy for contraceptives. They may also face barriers to access related to geographic
availability or conflicting beliefs of potential providers. Adolescents seeking
contraception without their parents’ support may encounter these barriers as well as
greater limits on personal finance, less access to transportation, and greater opposition
from prospective providers of contraceptive products and services (Guttmacher Institute,
2016c). Three additional barriers are higher for teens: confidentiality in accessing
contraception (Guttmacher Institute, 2016b), the legal right to access contraception
without parental consent (Guttmacher Institute, 2016c), and the lack of opportunity to
learn about contraceptive methods (Stanger-Hall & Hall, 2011).
Only twelve states have laws protecting the medical privacy of adolescents
insured as dependents (Guttmacher Institute, 2016b). Parents often learn of their minor
and adult children’s contraceptive access in Explanation of Benefits (EOB) forms which
disclose any services provided to any beneficiary of the insurance plan (Guttmacher
Institute, 2016c). This can effectively eliminate insurance coverage for contraceptives for
minors with parents opposing their access. In many states, minors cannot legally offer
consent to services necessary to receive contraception from health care providers without
parental approval. For example, in Connecticut, Indiana, Louisiana, Michigan, Nebraska,
or South Dakota, a minor can only offer consent to treatment if they are married;
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Oklahoma and New Jersey additionally allow minors to consent if they have already been
pregnant, though not before they become pregnant (Guttmacher Institute, 2016c).
Uniquely, in Mississippi a minor can give consent to receive contraceptive services if
they have a letter from their clergy affirming their suitability to receive contraception
(Guttmacher Institute, 2016c).

Emergency Contraceptives
Single dose levonorgestrel products, marketed as Plan B One-Step by Teva
Pharmaceuticals and under various generic names (Take Action, Next Choice One-Dose,
My Way), are the most widely available and most commonly used of the three forms of
emergency contraception in general use in the United States today (American Society for
Emergency Contraception, 2013). Plan B One-Step costs about $48.00 while generic
versions average $41.00 (American Society for Emergency Contraception, 2013). Plan B
One-Step and its generics consist of a single dose, 1.5 mg levonorgestrel tablet which is
easy to use and rarely causes severe side-effects. The most commonly reported sideeffects are headaches, nausea and vomiting, and menstrual irregularity. Side-effects are
generally mild and short-lived. Levonorgestrel is intended to be used within 72 hours for
greater likelihood of preventing pregnancy. The drug is more effective the sooner after
intercourse it is taken. Efficacy drops constantly every hour following sex, but pregnancy
may be prevented when the dose is administered up to 120 hours after intercourse
(Gemzell-Danielsson, Berger, and Latikumar, 2012). Unlike mifepristone, levonorgestrel
is not an abortifacient and has no effect on a fertilized ovum (American Society for
Emergency Contraception, 2013).
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Ulipristal acetate is a single dose, prescription-only alternative to levonorgestrel.
Ulipristal is more effective as an emergency contraceptive in that its efficacy remains
high for the full 120 hours following intercourse (Cleland et al., 2014). Like
Levonorgestrel, ulipristal blocks fertilization of the ovum. However, ulipristal has
significant contraindications and is inappropriate for women with renal disease, severe
asthma, or galactose intolerance; ulipristal has also not been as thoroughly studied in
adolescents (Koyama, Hagopian, and Linden, 2013). The fact that a prescription is
required and use is thereby likely to be delayed prevents wider use of ulipristal. The most
effective emergency contraceptive available is the copper intrauterine device (or IUD)
(Cleland et al., 2014). IUDs may be simple copper or may be embedded with
levonorgestrel. In either case, the copper ions released by the device are highly effective
in preventing fertilization of the ovum (Cleland, Raymond, Westley, and Trussell, 2014).
However, the necessity for the IUD to be inserted in a timely manner in a clinical setting
prevents more frequent use as an emergency contraceptive (Cleland et al., 2014). A
thorough description of the chemical mechanisms of action of levonorgestrel, ulipristal
acetate, and intrauterine devices follows in Chapter 2.

The Regulatory History of Levonorgestrel
As early as the mid-1960s, doctors administered high doses of estrogen to rape
victims to prevent pregnancy. In the 1970s, the safer Yuzpe method was developed which
combined progestin with a lower dose of estrogen. In 1998, the U.S. Food and Drug
Administration approved the Preven Emergency Contraception Kit consisting of two pills
(0.25 mg levonorgestrel and 0.05 mg estradiol) to be taken immediately and a second
dose of two pills to be taken 12 hours later (Stacey, 2014). In 1999, this was further
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improved upon with the approval of levonorgestrel-only Plan B One-Step. In February
2001, the Center for Reproductive Rights filed a petition with the FDA to make Plan B
available over-the-counter. In December 2003, the FDA’s Nonprescription Drugs
committee and the Reproductive Health committee each unanimously ruled that Plan B
was safe and effective (Stacey, 2014).
Even so, in May 2004, the Food and Drug Administration denied Plan B’s
manufacturer permission to begin sales due to concerns about adolescent sexual behavior
and health. In June of 2004, Senators Hillary Clinton and Patty Murray requested a
General Accounting Office audit of the FDA’s decision. In July, Plan B’s manufacturer
submitted a revised request for over-the-counter status for women age 16 or older
(Stacey, 2014). In January 2005, in response to the FDA’s failure to rule on the over-thecounter status of Plan B, Senators Clinton and Murray blocked President Bush’s nominee
Lester Crawford to FDA commissioner. The senators lifted their hold after being assured
that the FDA would rule on the matter by September 1, 2005. Instead, on August 26th,
Commissioner Crawford postponed the decision citing a need for public comment,
overruling the FDA’s own experts (Stacey, 2014). Under pressure from the U.S. Senate
and the GAO, Crawford resigned after just two months as commissioner. President Bush
nominated his own former physician Andrew von Eschenbach to head the FDA. Senators
Clinton and Murray blocked von Eschenbach’s appointment and demanded a decision on
Plan B. In June of 2006 the FDA formally denied the Center for Reproductive Rights’
petition and on August 24, 2006 announced that Plan B would only be available over-thecounter to women 18 and older (Stacey, 2014).
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In March of 2009, ruling in Tummino vs. Torti, Judge Edward Korman ruled that
the Food and Drug Administration’s denial of the Center for Reproductive Rights petition
was “arbitrary and capricious” and ordered the FDA to allow 17 year olds over-thecounter access to Plan B (Stacey, 2014). The FDA did so in July 2009 as part of the
introduction of Plan B One-Step, the one pill levonorgestrel formulation. One-Step was
made available to both women and men age 17 and older without prescription and
production of the older multi-pill formulas ended that summer (Stacey, 2014).
In February 2011, Plan B’s manufacturer requested that One-Step be sold overthe-counter without age restriction. In December, the Food and Drug Administration
approved this request only to be immediately overruled by Kathleen Sibelius, Secretary
of the Department of Health and Human Services. Secretary Sibelius argued that more
research should be done before making Plan B One-Step available to young adolescents
(Stacey, 2014). In February 2012, Judge Korman ordered the FDA to show cause for not
making Plan B available over-the-counter. On April 5, 2013 Korman reversed the FDA’s
rejection of the Center for Reproductive Rights’ citizen petition and ordered the FDA to
approve levonorgestrel EC products for OTC sale without age restriction within 30 days.
On April 30, the FDA instead ruled that Plan B One-Step would become available on
pharmacy shelves for women age 15 and up (Stacey, 2014). On May 1, 2013 the Justice
Department appealed Judge Korman’s order to make levonorgestrel products over-thecounter without restriction; Korman denied the appeal. On May 13th, the Justice
Department appealed to the Second U.S Circuit Court and was again denied. On June 20,
2013 the Food and Drug Administration approved Plan B One-Step to be sold over-thecounter and on store shelves to women and men without age or identification
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requirements. On February 25, 2014 the FDA also approved generic levonorgestrel
products to be sold over-the-counter and on store shelves without restriction, though
packaging still stated that the product was intended for ages 17 and older (Stacey, 2014).

Barriers to Emergency Contraception Access
Several barriers may prevent access to emergency contraception. While lack of
knowledge of the existence of EC, of how to obtain EC, or of the timing limits for
successful use of EC could limit a potential user’s access to and timely use of EC, these
barriers are beyond the scope of this thesis. Rather, this thesis will focus on pharmacybased barriers to EC access. Once a young woman has decided to seek emergency
contraception, several factors may prevent her from obtaining EC from a pharmacy in a
timely manner (Mackin and Clark, 2011). For the purpose of this thesis, these barriers to
access can be characterized as economic barriers, physical barriers, and staff-introduced
barriers such as lack of knowledge on the part of pharmacy staff and beliefs of pharmacy
staff which may motivate them to prevent access to EC.

Economic Barriers
The cost of emergency contraception presents a barrier to access for many
women. This is especially the case for adolescents who may attempt to purchase EC
without their parents’ permission (Guttmacher Institute, 2016c). The average cost of Plan
B One-Step ($48) or generic levonorgestrel ($41) (American Society for Emergency
Contraception, 2013) is generally covered by insurance, but adolescents may not have
access to their own insurance cards or may believe that the insurance charges will be
visible to their parents. Also, some insurers may not pay for the drug if not prescribed by
a physician (American Society for Emergency Contraception, 2013). One recent study
indicated that public subsidies of oral contraceptives more than pay for themselves in
8

savings of subsidized pregnancy-related costs (Foster, Biggs, Phillips, Grindlay, and
Grossman, 2015).

Physical Barriers
Some physical barriers exist within pharmacies themselves. For example, given
the economic barriers associated with EC, products such as Plan B may be considered
high-theft items and therefore kept in an enclosed case or behind the pharmacist’s counter
(American Society for Emergency Contraception, 2014). Also, many pharmacies have
reported not carrying EC products due to low demand (Mackin and Clark, 2011). It is
unknown to what extent not regularly carrying EC may discourage customers from
expecting to find the product and entering the store to obtain it, thus reinforcing the
pharmacist’s perception of a lack of demand. On a similar note, while the pharmacy may
only be temporarily out of stock of the product, since the efficacy of emergency
contraceptives drops continually following the time of intercourse, any delay is a
substantial barrier (Gemzell-Danielsson, et al., 2012). Alternatively, women may need to
travel long distances in rural areas or via difficult public-transit routes in urban areas to
reach a pharmacy with EC in-stock. These are also pharmacy-based physical barriers,
though they are external to the pharmacy.

Pharmacy Staff Lack of Knowledge
Researchers have found lack of knowledge on the part of pharmacists and other
pharmacy staff to be the source of significant barriers to access of emergency
contraception for adolescents and for women generally (Gaffaney, Stamm, Borgelt, Chau,
Rupp, Blumhagen, and Gilroy, 2015). The foremost barrier to access for adolescents
arising from lack of knowledge is that pharmacy staffs are often unaware of the fact that
levonorgestrel products are now available without prescription for any individual
9

requesting them (Wilkinson, Vargas, Fahey, Suther, and Silverstein, 2015). An associated
barrier is the improper demand for personal identification. Pharmacists and other
pharmacy staff also are often unaware that men can legally purchase emergency
contraception. Multiple studies have recognized the important role male partners and
other allies can play in assisting young women in obtaining EC (e.g., Fallon, 2010;
Schrager, Olson, Beharry, Belzer, Goldsich, Desai, and Clark, 2014). Also, staff lack of
knowledge can present a barrier to access to the proper form of EC for a given patient.
Studies have shown significantly decreased efficacy of levonorgestrel products in obese
women; these patients should be directed to seek other forms of emergency contraception
instead of or in addition to levonorgestrel (Gaffaney, et al., 2015).

Pharmacy Staff Beliefs
Though economic barriers, physical barriers, and barriers arising from lack of
knowledge among pharmacy staff are significant limiting factors to EC access, the beliefs
of pharmacists and other pharmacy staff may present some of the barriers to access for
adolescents seeking emergency contraceptives. Studies of the availability of EC in
southern and western states have shown substantial barriers to access, especially in rural
areas (e.g., Mackin and Clark, 2011; Samson, Loren, Downing, Schroeppel, Kelly, and
Ramaswamy, 2013; Gaffaney, et at., 2015). Recent surveys of pharmacists’ attitudes have
indicated that this lack of access is not the product of economic or physical barriers alone
(Richman, Daley, Baldwin, Kromey, O’Rourke, and Perrin, 2012). A lack of knowledge
on the part of pharmacy staff has been shown to be correlated to beliefs that would tend
to indicate opposition to EC access and a desire to erect barriers to access (Wilkinson,
Vargas, Fahey, Suther, and Silverstein, 2014). In the absence of a proper scientific
understanding of the chemical mechanism of levonorgestrel products, pharmacists may
10

rely on their moral beliefs concerning abortion to make decisions effecting access to EC
by adolescent girls and women generally(Wilkinson, et.al., 2014). Despite recent and
extensive research asserting that levonorgestrel poses no teratogenic effects and cannot
function as an abortifacient (e.g., Glasier, 2013; Gemzell-Danielsson, 2012), multiple
studies show pharmacists to believe that Plan B and its generics induce abortion and can
cause birth-defects when not successfully preventing pregnancy (Richman, et al., 2012;
Mackin and Clark, 2011).
In addition to doubts about levonorgestrel’s safety when used as directed,
pharmacists have reported doubt that adolescent females can successfully understand
directions for use of the product and that over-the-counter EC is therefore not safe for use
by adolescents without the direction of parents or medical professionals (Richman, et al.,
2012). Also, in addition to the well documented safety of levonorgestrel products,
multiple studies have found that adolescents are indeed capable of understanding the
directions for proper use and of using the product properly with a negligible rate of
complication (Raine, Ricciotti, Sokoloff, Brown, Hummel, and Harper, 2012; Manski and
Kottke, 2015). Along with beliefs relating to supposed abortifacient and teratogenic
properties, belief that adolescents cannot understand how to swallow a single pill
correctly may derive much more from pharmacists’ personal beliefs than from experience
or formal training (Wilkinson, et al., 2014).

Need for Further Study
The relevant literature describes many barriers to access to emergency
contraception and its effective use. These studies leave many unanswered questions. For
example, many studies of EC availability in urban and rural areas, though published
11

recently, are based on data collected before the 2013 FDA regulatory change of the legal
age for over-the-counter access. Studies of access in urban areas vs. in rural areas have
been conducted in Iowa and Kansas, states which may not be demographically
representative of many others. Conversely, studies of urban barriers to EC have been
conducted in New York City, but have not, for example, included comparisons to access
in rural areas such as upstate New York.
In addition to the need for more study of barriers related to emergency
contraception, there is even greater need for study of barriers to adolescent access. The
relevant literature demonstrates that sexually active and potentially active female
adolescents have a severe lack of understanding of the availability of EC and face much
greater barriers to access than do adult women (Yen, Parmar, Lin, and Ammerman,
2015). Pharmacy based studies of adolescent access to EC have been conducted in Iowa,
Kansas, and Wyoming but not in the American south. Among southern states, only
Florida has been the subject of a statewide survey of pharmacists’ knowledge of and
attitudes toward EC. To date, no studies have considered barriers to adolescent access to
Emergency Contraception in Kentucky.

Purpose of the Study
The purpose of this study is to gather previously unavailable information on the
barriers to access of Emergency Contraception for adolescents in Kentucky. The specific
research questions addressed by this study are as follows:
1. Are there differences in/associations between affordability, physical
accessibility, pharmacy staff knowledge and pharmacy staff attitudes
based on whether a pharmacy is rural or urban?
12

2. Are there differences in/associations between affordability, physical
accessibility, pharmacy staff knowledge and pharmacy staff attitudes
based on whether a pharmacy is chain or privately owned?
3. Do factors such as whether a pharmacy is chain or privately operated
or whether it is urban or rural predict a pharmacy’s likelihood of
carrying EC?
4. Do factors such as whether a pharmacy is chain or privately operated
or whether it is urban or rural predict the level of EC knowledge
among pharmacy staff?
5. Do factors such as whether a pharmacy is chain or privately operated
or whether it is urban or rural predict the level of negative attitudes
demonstrated by pharmacy staff?
The study will attempt simulate the experience of an adolescent female seeking
access to over-the-counter emergency contraception in Kentucky pharmacies. This goal
will be achieved through a series of “secret-shopper” telephone interviews in which the
researcher presents herself as a 15-year-old girl asking questions about the “morning after
pill.” As the first study of its kind to be conducted in Kentucky, it will provide greatly
needed information on the availability of over-the-counter emergency contraception in
the state in generally and specifically for female adolescents. This research will not only
help identify any specific areas for intervention relating to adolescent access to EC in
Kentucky pharmacies, but it also has the potential to provide a framework for further
study of the nature of barriers to access in this and other states. Finally, the study will
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contribute to ongoing efforts to collect a larger body of data needed to improve current
understanding of access to emergency contraception in the entire United States.
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Chapter 2
REVIEW OF LITERATURE
The relevant literature on Emergency Contraception and over-the-counter EC
availability includes recent work clarifying the chemical mechanism of the available
types of EC; the ethical, social, and political factors related to the use and accessibility of
EC; and research into the barriers to over-the-counter EC access for all women and
specifically for adolescents. The literature also includes several studies which serve to
highlight specific needs for further study and public health interventions.

Varieties and Mechanisms of Emergency Contraception
The most recent peer-reviewed data available on the chemical mechanism and
efficacy of available forms of Emergency Contraception, including levonorgestrel,
ulipristal acetate, and intrauterine devices, is summarized and discussed by Cleland and
colleagues (2014). Levonorgestrel is the most readily available of the three primary
emergency contraception options. Levonorgestrel is available as a single dose, 1.5 mg pill
or less commonly as two .75 mg pills. It has been sold over-the-counter as Plan B OneStep (one dose) since 2009 and since August 2013 has been sold without age restrictions
(Cleland, Raymond, Westley, and Trussell, 2014). In February 2014, generic versions of

levonorgestrel were approved to be sold under the same conditions. Prescription only
ulipristal acetate 30 mg has been available since 2010 as Ella. Though Ella is apparently
slightly more effective than levonorgestrel, it is not yet available over-the-counter
(Cleland, et al., 2014).
Over-the-counter levonorgestrel has been found 81%-90% effective when taken
within the recommended timeframe of up to 72 hours (Kaiser Family Foundation, 2016).
15

Researchers have found that levonorgestrel use failed to prevent 0.6% - 3.1% pregnancies
in clinical trials, while ulipristal was effective in all but 0.9 – 2.1% of uses in clinical
trials. Ulipristal users were, on average, 42% less likely to become pregnant than
levonorgestrel users (Cleland, et al., 2014). Levonorgestrel has been demonstrated to
delay luteinizing hormone surge if used before ovulation but is not effective thereafter.
Unlike ulipristal, levonorgestrel cannot prevent follicular rupture or implantation of a
fertilized ovum. Unlike the abortifacient drug mifepristone, levonorgestrel has no effect
on an implanted, fertilized ovum and therefore has no abortifacient properties (Cleland, et
al., 2014).
The third most common emergency contraceptive method is the copper
intrauterine device. The IUD may be implanted up to five days following intercourse to
prevent pregnancy, though as with all EC methods, efficacy falls rapidly over that time
period. Copper IUD’s may or may not be impregnated with levonorgestrel; studies are
underway to determine the additional efficacy of this combination. Without an added
contraceptive drug, the copper ions in the IUD are believed to both interfere with sperm
function and induce inflammatory response in the uterine tissue, preventing pregnancy
via multiple mechanisms (Cleland, et al., 2014). This would explain the high efficacy of
the copper IUD. Though IUD implantation is the most effective of all EC methods
available (greater than 99.9% effectiveness) it is also the most difficult to obtain in a
timely and affordable manner and is thus also the least commonly used (Cleland, et al.,
2014). An extensive review of the current understanding of the chemical mechanisms of
these three forms of emergency contraception and also of mifepristone is available in
Gemzell-Danielsson, Berger, and Latikumar (2012).
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Researchers have found higher body weight to reduce the efficacy of oral
emergency contraceptives. Levonorgestrel may be much less effective for women with
BMIs above 26. Drugs which reduce the effectiveness of other oral contraceptives are
believed to lower the effectiveness of levonorgestrel, though to what extent, given the
high dose administered in EC formulations, is unknown (Cleland, et al., 2014). Both body
weight and drug interactions which apparently lower efficacy need further study.
Despite these limitations, side effects are relatively mild and pass quickly in most
cases. The most common side effects reported were nausea and menstrual irregularity. No
serious complications or deaths have been linked to oral emergency contraceptive use and
levonorgestrel poses no known serious health risks to women or teratogenic risks to
children born in case of failure of the drug to prevent pregnancy. Oral EC is, in fact,
known to be safer than IUD insertion for women with pelvic inflammatory disease,
cervicitis, chlamydia, or active gonorrhea (Cleland, et al., 2014).
Koyama, Hagopian, and Linden (2013) have presented further possible
contraindications for ulipristal and thus reaffirmed the greater relative safety of
levonorgestrel. Among these are glucocorticoids, which are used to treat asthma and
which may be rendered ineffective by ulipristal. The authors also list several drugs which
may decrease the effectiveness of ulipristal, including barbiturates, carbamazepine,
oxcarbazepine, phenytoin, rifampin, St. John’s Wort, and several anti-retrovirals
(Koyama, Hagopian, and Linden, 2013).

Glasier (2013) focuses on clinical outcomes of levonorgestrel and other
emergency contraceptive methods. This meta-analysis found that levonorgestrel, like
other progestogens, is exceptionally safe with an extremely low risk of adverse effects.
17

The author found no evidence of higher risk of ectopic pregnancy or birth defects due to
levonorgestrel use and no evidence of adverse developmental effects for adolescents
using the drug. The study also showed that side effects such as dysmenorrhea, fatigue,
abdominal pain, nausea, and headache are no greater for levonorgestrel users than for
participants in control groups taking no medications who were asked to keep daily diaries
of such minor complaints (Glasier, 2013).

Ethical, Social and Political Considerations
Lewis and Sullivan (2012) writing in Ethics and Medicine considered the ethical
arguments for health care providers and pharmacy staff to refuse to provide emergency
contraceptives such as levonorgestrel which have been specifically shown to have no
abortifacient properties. Having reviewed all available studies on levonorgestrel’s
chemical properties and mechanism, they found that moral claims based on belief that EC
functions as an abortifacient are fully baseless and untenable. They argue that such a
refusal of care has no basis in medical ethics (Lewis and Sullivan, 2012).
Price (2011) considered the role of sexual ethics and personal mores in the
construction of public policy concerning access to emergency contraception for
adolescents and found that desires to maintain parental authority and expectations of
sexual “purity” for teenage girls have been the primary causes for the subordination of
health policy to personal ethics. The author identified culturally and religiously based
fears and anxieties as giving rise to extreme discomfort with the existence of adolescent
sexuality. Parents tend to explain that providing access to contraceptives implies adult
permission for sexual activity. The author advocated acceptance of the fact of adolescent
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sexuality and the formulation of public policy on that basis rather than attempts to placate
parents’ discomfort with teen sexual activity (Price, 2011).
A similar argument is made by Thompson and colleagues (2013). The authors
discuss the past regulation of emergency contraception on the basis of political influences
and social concerns rather than medical fact and public health data. Their argument,
however, focuses more on the overwhelming scientific research in favor of permitting
unrestricted access to oral emergency contraceptives. The authors note that a 2009 study
found that fewer than one in ten thousand EC users were younger than age 13. They also
review data specifically on the safety of Plan B One-Step for adolescents aged 13-16 and
find age restrictions to be medically unjustifiable and an unnecessary barrier to access
(Thompson, Raine, Foster, Speidel, Darney, Brindis, and Harper, 2013).
The authors of the official position statement of the Women’s Health Practice and
Research Network of The American College of Clinical Pharmacy argue that pharmacists
have a duty to advocate for the patients’ right to access emergency contraception and to
facilitate access in their own pharmacies and beyond by ensuring timely access, lowering
barriers to access, and educating their patients on proper emergency contraceptive use
(Rafie, McIntosh, Gardner, Gawronski, Karaoui, Koepf, and Patel-Shori, 2013).

Barriers: Economic and Physical
No extensive analysis of the role of cost as an economic barrier to access to
emergency contraception has yet been conducted. Though not specifically on emergency
contraception, Foster and colleagues (2015) argue that cost may be the most important
barrier to access to oral contraceptives in general. Econometric analysis correlating
income level to likelihood of use of oral contraceptives in general led the researchers to
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determine that, assuming no additional cost to the consumer, up to an additional 21% of
women might use oral contraceptives. Depending on other factors, this would result in a
7% to 25% decrease in unwanted pregnancies. The authors find that providing low or no
cost contraceptive coverage to low income women would radically lower healthcare costs
(Foster, Biggs, Phillips, Grindlay, and Grossman, 2015). A similar argument would likely
hold true for EC subsidization.
Studies of access to emergency contraception in urban areas have produced
somewhat contradictory results. Bell, Camacho, and Velasquez (2014) intended to study
availability of emergency contraception to men posing as mystery shoppers in various
New York City neighborhoods. The study found the men were able to access EC 80% of
the time and determined that economic barriers were the most significant impediments to
access. The authors noted that pharmacies in lower socio-economic status neighborhoods
had more restrictive hours and that the men had to travel to higher socio-economic status
neighborhoods to access EC during those times, presenting a barrier to access. Legare
and colleagues (2012) found no significant same-day availability of EC: 94 % available
in East Harlem pharmacies and 93% on the Upper East Side. Given that average cost was
$45.16 in East Harlem and $51.64 in Upper East Side pharmacies, the authors concluded
these prices to be relatively low barriers to access (Legare, Bakshi, Keyhani, and Howell,
2012). These studies indicate that in urban areas, if a given pharmacy does not have
same-day availability, a nearby pharmacy likely will. In urban areas, therefore, economic
barriers may pose the greater relative barrier to access.
Other economic and physical barriers to access are likely in rural areas. Mackin
and Clark (2011) studied availability of emergency contraception in Iowa pharmacies
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before and after the 2006 FDA decision to make Plan B One-Step available without
prescription. Though the number of pharmacies carrying Plan B increased from 57.8% to
70% following the change, the number of pharmacies reporting lack of demand as their
reason for not carrying EC remained consistent: 67.5% before and 66.7 % after. This
limitation to access is likely self-perpetuating. After moral objections, low demand was
the primary reason cited by pharmacists who chose to not carry EC. Where EC is not
regularly available, shoppers may be discouraged from requesting it, reinforcing the
perception of lack of demand (Mackin and Clark, 2011).
Samson and colleagues (2013) conducted a survey designed to ascertain
differences in availability at urban and rural pharmacies in Kansas. Researchers
telephoned 201 pharmacies selected by random number generator. One hundred eightysix pharmacists agreed to be interviewed. Pharmacists were asked if they carried EC and
if it was currently in stock or available in 24 hours. Eighty-five percent of urban
pharmacies could dispense EC within 24 hours while only 75% of rural pharmacies
could. However, urban pharmacies were almost twice as likely to have EC in stock at the
time of request. Further, urban pharmacies which were out of stock of EC were often
corporate chain pharmacies which could direct patients to another branch nearby. The
authors found that rural, independent pharmacies were least likely to carry EC, to have
EC in current stock, or to be able to dispense EC within 24 hours (Samson, Loren,
Downing, Schroeppel, Kelly, and Ramaswamy, 2013).
Other researchers conducted a similar study in which secret shoppers called each
of the 66 retail pharmacies in Wyoming. Gaffaney and colleagues (2015) asked a series
of questions about EC location in the store, age and ID requirements, weight
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appropriateness, and if the product was in stock. Since the survey was conducted after the
June 2013 approval for OTC access without age restriction, complete accessibility was
defined as in stock, on the shelf, and accessible without age or ID requirements. By these
standards, only 10 of 63 pharmacies from which information was successfully gathered
offered complete accessibility. Fifty-six pharmacies reported that emergency
contraception was in stock. Thirty-six of the 63 pharmacies improperly imposed an ID
requirement (Gaffaney, Stamm, Borgelt, Chau, Rupp, Blumhagen, and Gilroy, 2015).
Given the recent change in regulatory status of EC products, it is difficult to determine
whether and to what extent confusion or intent to avoid selling EC played a role in
inaccessibility.
Many researchers have found that women in rural communities face significant
physical barriers to EC access in the form of absence from store shelves and the added
economic barrier of travel to another community to find the product in a timely manner
(e.g., Mackin and Clark, 2011; Samson et al., 2013; and Gaffaney et al., 2015). In
recognition of the fact of lower rural accessibility, Kelleher (2010) discusses the viability
of a so-called moderate solution to pharmacist refusal to provide EC. The author
examines the reasonability of allowing urban pharmacists to decline to provide EC given
the supposed greater availability of EC in a given urban area. Kelleher rejected an urbanonly pharmacy opt-out option, arguing that many of the same factors limiting access in
rural communities may apply in low-income urban neighborhoods. Women in low socioeconomic status neighborhoods may lack the money or free time to travel to other
neighborhoods and to require them to so do would represent an unjustifiable barrier to
access (Kelleher, 2010).
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Barriers: Pharmacy Staff’s Lack of Knowledge
In an extensive study of emergency contraception access conducted in five
American cities, Wilkinson and colleagues (2012) used secret shoppers to contact 943
pharmacies and had them present themselves as either as 17-year-olds requesting
emergency contraception or as physicians requesting EC for their 17-year-old patients.
Nineteen percent of pharmacies told “adolescent” callers it would be impossible for the
pharmacy to dispense EC to them under any circumstances. Only 3% of physicians were
told this. Only 57% of adolescents and 61% of physicians were told the correct age (at
the time of the survey) for access to EC without prescription. That physicians were told
incorrect data at a frequency near that for adolescents arguably indicates lack of
knowledge more than intent to deceive (Wilkinson, Fahey, Shields, Suther, Cabral, and
Silverstein, 2012). In a follow-up article to the same study, Wilkinson and other
colleagues note that pharmacy staff often displayed confusion over EC regulations,
imposed improper barriers to access, and were apparently unaware of their obligation to
maintain confidentiality even for minor patients (Wilkinson, Vargas, Fahey, Suther, and
Silverstein, 2015).
Researchers Young, Griffin, and Vest (2013) found that pharmacy students
nearing completion of their degree are aware of their lack of knowledge of emergency
contraception and that schools of pharmacy may not be adequately preparing new
pharmacists for their responsibility to adolescent EC users. In a teaching exercise
conducted at Midwestern University Chicago College of Pharmacy, two hundred thirdyear pharmacy students observed skits and were partnered with classmates for practice in
emergency contraceptive counseling. Prior to the workshop, only 25% of the pharmacy
students reported confidence in counseling patients on emergency contraceptive use.
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Following participation in the exercise, 58.8% reported confidence in their counseling
ability. The most commonly self-reported barrier to self-efficacy in counseling was lack
of knowledge (Young, Griffin, and Vest, 2013).
Even in locales where most pharmacies were helpful and actively sought to make
emergency contraception available, lack of knowledge remains a barrier to access for
adolescents. Orr and colleagues (2015) describe data from telephone interactions in
which female researchers posing as patients seeking EC called Rhode Island pharmacies
in the spring of 2009 and again in spring of 2012. Ninety percent of pharmacies stocked
EC each year. Notably, however, the number of pharmacies which provided the correct
minimum legal age for purchase (prior to removal of that restriction in 2013) fell from
67% to 53%. The authors describe overall access to EC in Rhode Island as “very good”
and determined the misunderstanding of the legal age for over-the-counter access to
emergency contraception appears to be an honest mistake on the part of pharmacy staff
(Orr, Lemay, Wojtusik, Opydo-Rossoni, and Cohen, 2015).
After age requirements, another common misunderstanding on the part of
pharmacy staff is the belief that levonorgestrel and ulipristal act as abortifacients in a
manner similar to mifepristone. Though ample literature to the contrary as discussed
above is available, surveys of practicing pharmacists and other pharmacy staff find this
belief to be relatively common. Mackin and Clark’s (2011) study of Iowa pharmacies
before and after the 2006 FDA approval of over-the-counter access with age restrictions
found that following that change, 38% of Iowa pharmacists still reported that they
understood EC to function as an abortifacient.
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Richman and colleagues (2012) considered responses to a 2008 survey of 1,264
randomly selected pharmacists registered with the Florida Board of Pharmacy. Though
only 22% of selected pharmacists returned their unsolicited questionnaires and it is
improper to consider this sample representative of Florida pharmacists overall, their
responses nonetheless indicate the presence of significant barriers to EC access due to
lack of knowledge. Forty-six percent of respondents answered in the affirmative that EC
does induce abortion. Fifty-six percent of pharmacists responding reported that EC causes
birth defects, again, contrary to the overwhelming evidence to the contrary. Only 22% of
respondents correctly answered that EC could be purchased prior to need (Richman,
Daley, Baldwin, Kromey, O’Rourke, and Perrin, 2012).
Gaffaney and colleagues (2015) reported that in their survey of Wyoming
pharmacies conducted following the June 2013 removal of age and, therefore,
identification requirements, 36 of the 63 pharmacies surveyed nonetheless improperly
imposed an ID requirement. The authors also found that pharmacy staff at only 21 of the
63 pharmacies accurately communicated that emergency contraceptives are less effective
in obese women (Gaffaney, Stamm, Borgelt, Chau, Rupp, Blumhagen & Gilroy, 2015).
Sixty-one percent of Florida pharmacists surveyed by Richman and colleagues
(2012) expressed general “discomfort” with dispensing EC to adolescents. While
personal beliefs likely account for an indeterminable portion of this discomfort, Mackin
and colleagues (2011) found that while prior to 2006 43.8% of Iowa pharmacists
understood EC to be safe for adolescents, that percentage fell to 27.9% following the
change to over-the-counter status for Plan B. The thing that changed in that time was the
ability of teens to purchase Plan B without medical examination or extensive advising as
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to the proper use of the drug (Mackin, et al., 2011). Many pharmacists are apparently
unaware of or doubt the studies showing the high degree of safety for levonorgestrel
users or they doubt adolescents’ ability to understand the drug’s instructions and use it
properly.
Two recent studies have shown such concerns to be unfounded and the source of
unnecessary barriers to access. Manski and Kottke (2015) conducted a study of teen
attitudes to EC as gathered from a survey conducted via advertisements on Facebook.
Three hundred forty-eight females aged 14-17 years responded. Along with questions
concerning their sexual activity and attitudes, respondents participated in a brief tutorial
on key concepts necessary to understand for proper use of levonorgestrel. On average,
participants were able to understand 7.1 of 8 concepts needed for proper EC use without
further instruction (Manski and Kottke, 2015). Given that it would be reasonable to
expect that many adolescent or adult users might not achieve a perfect score on such a
quiz even if instructed by a doctor or pharmacist on proper use, it seems clear that the
great majority of adolescents are able to understand how to take the single dose in a
timely manner as instructed.
Raine and colleagues (2012) also examined the ability of adolescent females to
safely and properly use EC. The study considered, adolescents aged 11-17 who requested
EC at reproductive health centers in five U.S. cities were asked to read the product label
and describe to healthcare providers how to use the product. The EC product was then
dispensed to those patients who accurately understood the label instructions. Those
patients were contacted one, four, and eight weeks later for follow-up interviews. Over
nine in ten patients (91.5%) were able to understand the label and choose appropriately
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whether to use the EC product or not. About ninety-three percent (92.9%) of participants
used the product according to label instructions. Only 2.3% of participants who used the
product became pregnant. No participants reported adverse side-effects (Raine, Ricciotti,
Sokoloff, Brown, Hummel, and Harper, 2012). Again, these results would indicate that
few proposed restrictions on use by adolescents are medically justifiable.

Barriers: Pharmacy Staff’s Beliefs
As described above, the personal beliefs of parents and lawmakers have been
primary factors in shaping public health policy on adolescent access to emergency
contraception (Price, 2011; Thompson, et al., 2013). The beliefs of pharmacists and other
pharmacy staff also play a highly significant role in the imposition of barriers to EC
access. Many of the same studies that examine the role of lack of knowledge also
contribute to a greater understanding of the role of the beliefs of pharmacy staff on
adolescent access to emergency contraception. It appears that lack of scientific
knowledge on EC often correlates to a reliance on personal belief on the part of pharmacy
staff in making decisions concerning the dispensing of emergency contraception. For
example, Wilkinson and colleagues (2014) found that the same pharmacy staffs that
showed confusion and uncertainty as to emergency contraception regulations also
resorted to ethical terms when describing their own pharmacy’s policies on EC
availability. Despite extensive evidence of the absence of abortifacient properties cited
above, many pharmacists and other pharmacy workers believe use of or dispensing of
levonorgestrel emergency contraceptives to be a form of abortion and therefore morally
objectionable (Mackin and Clark, 2011; Richard, Kinzey, and Masters, 2015). Many
pharmacists also persist in the belief, shown to be false by Raine and colleagues (2012)
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and by Manski and Kottke (2015) that levonorgestrel is unsafe for adolescents without
medical and adult supervision.
As discussed above, Mackin and Clark (2011) found that 38% of pharmacists in
Iowa at the time they were surveyed believed Plan B to function as an abortifacient.
Likewise, Richman, et al. (2012) found that 46% of pharmacists responding to the survey
believed Plan B induces abortion. In both cases, it is difficult to know where
misunderstanding of chemical mechanism of levonorgestrel ends and personal beliefs
concerning abortion begin. However, neither study asked pharmacists both what they
understood about the chemical function of emergency contraception and their personal
beliefs concerning abortion.
An extensive recent study of pharmacist beliefs concerning the dispensing of
hormonal contraceptives in general was conducted in the rural town of Winchester,
Virginia. Richard, Kinzey, and Masters (2015) sent surveys to each of the town’s 52
pharmacists, who work in 32 pharmacies, in March of 2011. The survey had a 63%
response rate. The survey questioned attitudes toward hormonal contraceptives generally,
but not EC specifically. Fifty-four percent of responding pharmacists opposed
prescription of hormonal contraception by pharmacists. Ninety-five percent opposed
over-the-counter access to any hormonal contraceptives and 71% did not even support
behind-the-counter access. Eighty percent of pharmacists responding doubted their
patients’ ability to self-screen for contraindications (Richard, Kinzey, and Masters, 2015).
This opposition on the part of Winchester, Virginia’s pharmacists is in extreme contrast
to the relative ease of access observed by Orr and colleagues (2015) in their survey of
Rhode Island pharmacies or by Legare and colleagues (2012) in their study of New York
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City pharmacies. These findings strongly indicate that in many rural communities there
may be very little advocacy for expanded access to contraceptives of any kind on the part
of pharmacists, let alone support for greater access to emergency contraceptives.

Need for Further Study and Public Health Interventions
Writing prior to the 2013 expansion of availability, Devine (2012) seeks to
explain the failure of EC to lower the rate of unintended pregnancy despite prescription
availability for three decades and over-the-counter availability since 2006. The author
attributes this lack of effectiveness to a combination of lack of awareness of the nature of
EC and its over-the-counter status, the incorrect belief that EC is an abortifacient, privacy
concerns, and concerns over adverse health effects. Further study will be necessary to
determine if the 2013 expansion of access contributed to greater utilization of EC.
Baird and colleagues (2015) also discuss the failure of greater EC availability to
lower the rate of unintended pregnancy. The authors note that all approved forms of
emergency contraceptives are less effective than regular use of any other physical or
hormonal contraceptives available. Along with the need for greater public awareness of
and access to emergency contraception, the authors advocate public health interventions
aimed at ensuring that women who use EC will transition successfully afterwards to
regular, more effective birth control methods and to prevent overreliance on EC as a birth
control method (Baird, Cameron, Evers, Gemzell-Danielsson, Glasier, Moreau, and
Volpe, 2015).
Melton, Stanford, and Dewitt (2012) specifically studied the potential problem of
overreliance on EC as a primary form of contraceptive. The authors are concerned that
many women in a Utah survey of emergency contraception use reported using EC more
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than once in the previous year. Echoing other researchers’ concerns that women should
be encouraged to begin a regular contraceptive method following EC use, the authors
warn against the alternative of accidentally instilling an overly high estimation of the
efficacy of EC. Levonorgestrel pills were believed to be about 77% effective as of the
most recent data available at the time of the survey. Of the women surveyed, 58%
believed Plan B to be 90% effective and 16% reported belief that it is nearly 100%
effective. The authors assert that women who repeatedly use EC successfully likely
overestimate its effectiveness (Melton, Stanford, and Dewitt, 2012). Efforts to increase
access should be wary of inducing dependence on EC as more than a backup method of
contraception.
Researchers have also studied the possibility that increased availability of EC in
pharmacies may result in fewer sexual assault victims seeing help in emergency rooms.
Gross, Lafortune, and Low (2014) speculate that this would lead to a lower rate of
reporting of sexual assaults and prevent timely collection of physical evidence of assault.
The authors do not assert that they have conclusively proven this hypothesis and research
is ongoing, but they highlight the need for pharmacists and public health professionals to
consider this possibility when implementing any plan to increase accessibility of EC.
Durrance (2013), writing in Economic Inquiry considered a possible correlation
between trends in sexually transmitted infections and the increased access to EC. Acting
to increase access to emergency contraception many years before over-the-counter status
was approved by the FDA in 2006, Washington State officials allowed pharmacists to
begin prescribing EC in 1998. Following that change, rates of gonorrhea infections both
in women and in men rose in significant correlation to the increase in EC availability at
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the county level. The author has been unable to discount this correlation with falsification
tests. It may be that pharmacies were simply more likely to provide greater EC access in
counties that were already trending toward more unsafe sexual contact in response to that
need; an upward trend in unsafe sex would explain both greater need or EC and a raise in
STD infections. In any case, any such trend requires explanation.
In a recent broader study, Atkins and Bradford (2015) also considered the
possibility that greater access to emergency contraception could lead to greater sexual
risk taking by women. Their data set was collected for the National Longitudinal Survey
of Youth from October 1999 through November 2009 on 3,786 women age 18 and over.
This provided data from years before and after the 2006 FDA decision to allow states to
permit pharmacies to provide EC over-the-counter, without prescription. The data set also
included women in states with and without over-the-counter EC. The authors were able
to consider variables including frequency of sexual activity, number of partners, condom
use, etc. The researchers found no relationship between the 2006 national policy change
and probability of sexual activity, likelihood of unprotected sexual activity, or number of
sexual partnerships (Atkins and Bradford, 2015). Women in the states which chose to
make EC available without prescription did report greater likelihood of unprotected sex,
though this may correlate to the variance in sexual mores by state or with the passage of
time rather than indicate a causal relationship to the change in EC availability.
Several researchers have recognized and studied the role of sexual partners and
other allies in accessing emergency contraception. Bell, Camacho, and Velásquez, (2014)
sent male mystery shoppers into pharmacies in three New York City neighborhoods to
request EC. While almost three-quarters of pharmacies (73.3%) were considered by the
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authors to have presented some barriers to EC access, the most common barriers to
access were found to be limited hours in lower socio-economic status neighborhoods and
higher cost in higher socio-economic status neighborhoods. Despite various barriers, the
male mystery shoppers in the study were able to access EC 80% of the time (Bell,
Camacho, and Velásquez, 2014).
Schrager and colleagues (2014) reported the findings of surveys of 198 new
patients at two Los Angeles primary care clinics on their past use of, knowledge of, and
attitudes toward emergency contraception. Only about half of women and one third of
men knew EC was available without prescription. Only 24% knew that males could
purchase EC for partners (Schrager, Olson, Beharry, Belzer, Goldsich, Desai, and Clark,
2014). These studies indicate that greater public health education efforts aimed at men
and at informing women that their male partners can help them obtain EC in a timely
manner.
Through a qualitative study of the experiences of adolescent females in accessing
EC, Fallon (2010) explores how teens have relied on peers to deal with shame and
barriers to access of EC. The girls interviewed described their efforts in helping each
other to obtain EC confidentially and understand how to use the product properly. Fallon
(2010) finds that teens can assume supporting roles and shed labels associated with
underage sexual activity in favor of self-efficacy in the face of opposition to their access
to contraceptives. These findings have important implications for efforts to educate
minors about the use of and access to EC. While adolescent peers may not be ideal
reproductive care advocates, health professionals should realize that teens will likely turn
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to their peers for support. Public health education interventions should be designed with
such considerations in mind.
Several studies have found evidence of a general lack of knowledge as to the
nature of and availability of emergency contraception among female adolescents, women
in general, and the public overall. Yen and colleagues (2015) reported the results of
anonymous surveys of 439 uninsured young people aged 13 to 25 using the services of
mobile primary care provider in the San Francisco, California Bay Area from 2010 to
2012. The mean age of the respondents was 17.8 years and 66% of respondents were
women. Eighty-six percent of young women reported having heard of EC, but most
respondents had many misunderstandings about the nature of EC. Forty percent of
respondents incorrectly believed emergency contraception induced abortion. Forty-four
percent incorrectly believed EC had to be taken within 24 hours of intercourse. Only 40%
of the young women were aware that EC was available without prescription.
Additionally, 72% did not know that males could purchase EC for their partners (Yen,
Parmar, Lin, and Ammerman, 2015). In a similar study of 226 young females aged 14-19
years old presenting for treatment at two urban emergency departments Mollen and
colleagues (2013) likewise found significant lack of knowledge of the safety and
availability of EC. The majority of the teens surveyed expressed concern about long-term
(78% of respondents) and short-term (86%) adverse side-effects. Forty-five percent
believed they needed a prescription and doubted they would be able to get one quickly
(Mollen, Miller, Hayes, and Barg, 2013).

The above information demonstrates that a need exists for public health
interventions to educate young women, pharmacy staff, and indeed the general public
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about the use, efficacy, and availability of emergency contraceptives. Several
interventions have in fact been completed in pharmacy settings which have been shown
to significantly increase patients’ and pharmacy staffs’ knowledge and reduce barriers to
EC access. Ragland, Payakachat, and Stafford (2015) describe the results of an
intervention conducted in a retail pharmacy setting over the course of two months in
2012. Pharmacy students counseled female participants for ten minutes on the basics of
use of and access to EC. Participants were tested before counseling to establish what the
women already knew and were tested again following counseling. The women were also
contacted by telephone 1 to 3 months later for a follow-up test. Tests immediately after
counseling showed significant increase in understanding of EC. The follow-up tests also
showed significantly higher scores (Ragland, Payakachat, and Stafford, 2015). These
results show that minimal time spent educating patients in a pharmacy setting can lead to
an immediate and long-lasting increase in understanding of EC related information.
Batra, Aquilino, and Farris (2015) evaluated pharmacy staff survey results following a
two year intervention designed to reduce unplanned pregnancy in women aged 18 to 30
in 12 Iowa counties. The staff had all participated in online education and campaign
materials such as posters and brochures were available in the 55 pharmacies included in
the intervention. Though the study did not focus on emergency contraception, the authors
significantly found that 90% of participating staff found discussing contraceptive use
with patients easy after the intervention and expressed a desire to prioritize the topic
(Batra, Aquilino, and Farris, 2015). That the Iowa pharmacy staff became more open to
discussing contraception in general does not necessarily imply an increased desire to
provide EC. This emphasizes the need for the integration of EC specific education into
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any intervention designed to improve pharmacy staff dialog with women on
contraceptives in general.
Finally, Young, Griffin, and Vest (2013) described the results of a teaching
exercise conducted at Midwestern University Chicago College of Pharmacy. Two
hundred third-year pharmacy students observed skits and were partnered with classmates
for practice in emergency contraceptive counseling. Prior to the workshop, only 25% of
the pharmacy students reported confidence in counseling patients on emergency
contraceptive use. Following participation in the exercise, 58.8% reported confidence in
their counseling ability. The most commonly self-reported barrier to self-efficacy in
counseling was lack of knowledge (Young, Griffin, and Vest, 2013). The results of this
workshop indicate that significant gains in EC counseling skills pharmacists can be
achieved with minimal additional instruction and practice. Though the practice partners
were adult pharmacy students, the workshop results indicate that education and practice
in counseling minors could produce equal or greater increases in pharmacists’ knowledge
and comfort with counseling adolescents on EC use.
The relevant literature affirms the safety of levonorgestrel EC products and
describes the social rather than scientific basis of opposition to greater access to
Emergency Contraception and the resulting barriers. Much of the relevant literature is
designed to explore and understand those barriers, but this research is limited in scope.
Specifically, the only studies conducted in the southern United States have been surveys
of pharmacists in Florida and in Winchester, Virginia. While more extensive statewide
studies have been conducted in Iowa, Kansas, Rhode Island, and Wyoming, barriers to
EC in these states may not be representative of barriers to EC access elsewhere. These
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studies do, however, demonstrate the feasibility of collecting valuable data on barriers to
EC, specifically via “secret shopper” interviews. The opportunity to expand the literature
to include a study of over-the-counter EC access in Kentucky and to improve upon both
the selection of questions to be asked and the analysis of the data collected provides a
strong rationale for the study.
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Chapter 3
METHODOLOGY
This study simulated the experience of an adolescent female seeking access to
over-the-counter emergency birth control in Kentucky pharmacies. A cross-sectional,
mixed-methods study was developed to gather descriptive information and data that can
yield answers to the following research questions:
1. Are there differences in/associations between affordability, physical
accessibility, pharmacy staff knowledge and pharmacy staff attitudes
based on whether a pharmacy is rural or urban?
2. Are there differences in/associations between affordability, physical
accessibility, pharmacy staff knowledge and pharmacy staff attitudes
based on whether a pharmacy is chain or privately owned?
3. Do factors such as whether a pharmacy is chain or privately operated
or whether it is urban or rural predict a pharmacy’s likelihood of
carrying EC?
4. Do factors such as whether a pharmacy is chain or privately operated
or whether it is urban or rural predict the level of EC knowledge
among pharmacy staff?
5. Do factors such as whether a pharmacy is chain or privately operated
or whether it is urban or rural predict the level of negative attitudes
demonstrated by pharmacy staff?
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Study Design and Justification
Data collection began in July 2016, after receiving approval from Western
Kentucky University’s Institutional Review Board. The researcher telephoned selected
Kentucky pharmacies in the sample areas posing as a potential customer, known as a
“secret shopper” study when used in market research. The caller presented herself as a
15-year-old female who had unprotected sex two days prior to the phone call and needed
more information on the product. The age was chosen based on the 2013 change to the
law that allows anyone to purchase EC over the counter without a prescription rather than
restricting purchase to people aged 17 years and older. The caller followed a semistructured script designed to assess pharmacy staff knowledge of levonorgestrel
(effectiveness, function, etc.), knowledge of the legal status of levonorgestrel, and
financial and physical accessibility.
Although the “secret shopper” design involved a level of deception, this research
approach has been used successfully in previous studies assessing adolescent access to
over-the-counter emergency contraception. In an extensive study of emergency
contraceptive access conducted in five American cities, Wilkinson, Fahey, Shields,
Suther, Cabral, and Silverstein (2012) used secret shoppers to contact 943 pharmacies by
phone and had them pose either as 17-year-olds requesting emergency contraception or as
physicians requesting EC for their 17-year-old patients. In another study, Orr, Lemay,
Wojtusik, Opydo-Rossoni, and Cohen (2015) collected aggregate data from telephone
interactions in which female researchers posing as patients seeking EC called Rhode
Island pharmacies in the spring of 2009 and again in spring of 2012. In order to
determine if a girl’s sexual partner or male family member would experience difficulties
obtaining emergency contraception, Bell, Camacho, and Velásquez, (2014) sent male
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mystery shoppers into pharmacies in three New York City neighborhoods to understand
their experience. The design of this research was based on previously-established ‘secret
shopper’ study designs such as those mentioned above.
Each pharmacy was contacted one time via telephone. If the call was answered,
this met the criteria for having made ‘contact,’ and the pharmacy would not be
telephoned again regardless of whether or not any useful information was obtained. If the
call was left unanswered, the pharmacy would be highlighted in the sampling frame to
receive a call at another time. Phone calls were made from a quiet, private room in the
researcher’s home on weekdays between the hours of 8am and 6pm since these are the
typical pharmacy operating hours. The researcher, presenting herself as a 15-year-old
girl, followed the semi-structured script with whomever first answered the phone. While
the caller never requested a transfer to the pharmacist, often the original respondent
would transfer anyway. If the original call was transferred to a second person (for
example, if a pharmacy technician transferred the call to a pharmacist), the caller would
continue the interview with the second person and record the job title of the highestranking person interviewed.

Sample and Sampling Frame
Kentucky is divided into five regions: The Jackson Purchase, the Western Coal
Fields, the Bluegrass Region, the Mississippi Plateau, and the Cumberland Plateau
(Clotter, 2000). Using a purposive sampling technique to determine which counties to
request for inclusion in the sampling frame, the counties included were from each of the
major Kentucky regions as well as urban, rural non-Appalachian, and Appalachian areas.
The rural sampling frame consisted of 7 counties randomly selected from the Jackson
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Purchase, Mississippi Plateau, and Western Coal Fields regions (mostly rural regions).
The Appalachian sampling frame consisted of all listed pharmacies from 7 counties
randomly selected from the Cumberland Plateau region. The rurality of the selected
counties was verified using county demographic information available on the County
Health Rankings and Roadmaps website (University of Wisconsin Population Health
Institute, 2016). If a county was over 33% rural, it qualified for inclusion. Every
operating pharmacy in the rural and Appalachian counties included in the sampling frame
was contacted (n=95). The urban sample consisted of pharmacies randomly selected from
within the three largest urban areas in Kentucky: Louisville, Lexington, and Bowling
Green (n=125).
A list of licensed pharmacies in the selected counties and cities was obtained
through the Kentucky State Board of Pharmacies. After removing hospital and specialty
pharmacies, the list included 329 qualifying pharmacies. In total, 67% of all the
pharmacies listed in the sampling frame were contacted (n=220). However, only those
pharmacies that regularly stocked EC and had it available at the time of the call
completed a full interview (n=103).

Confidentiality
This study involved an analysis of aggregated data. Confidentiality was
maintained by not collecting the name of the person being interviewed or any other
identifying details. Further, while the address and name of the pharmacy were included in
the sampling frame, this information was not included in the final dataset. Pharmacies
were labeled as either rural (non-Appalachian), urban, or Appalachian and as either chain
or non-chain pharmacies. Pharmacies were not labeled by county or specific city. This
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non-specific labeling method allowed the researcher to answer the given research
questions while protecting the pharmacies sampled.

Call Scripts and Data Collection
The semi-structured interview script was designed to determine the physical
availability of EC in the pharmacy as well as the pharmacy staff’s understanding about
proper usage and legal requirements to obtain the drug. The script contained the
following questions:
1. Hi. I need to ask about something personal…you’re an adult…like over 18,
right? (This question was asked to prompt the respondent to confirm that they are
“over 18” or are presently 18 years of age, or are under 18 years of age, while
realistically sounding like the phrasing a 15-year-old would plausibly use.)
2. Do you carry the morning after pill? (If no: Can you recommend a pharmacy
that would have it?)
3. Can I get it now?
4. Do I need a prescription?
5. Well, I am 15, so do I need to bring my mom or something?
6. How long after sex before it doesn’t work anymore? (Recorded in hours)
7. Will it work for sure?
8. Is it the same like going and getting an abortion?
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9. Where can I find it in the store? (Asked to determine if it is available on an
aisle [customer does not have to interact with pharmacy staff], behind the
pharmacy counter [customer must interact with staff to obtain EC], or other)
10. How much does it cost? (Recorded cheapest option)
11. So are you the pharmacist or a tech or…? (Asked to determine the job of the
person interviewed)
After the person on the phone confirmed that they were 18 or older, the rest of the
interview continued as outlined in the flow chart included in Appendix I. The structured
interviews were pilot tested by calling pharmacies outside of Kentucky and, therefore,
outside the sampling frame. Data was hand-recorded on standardized forms and coded in
an Excel document. The Excel data was later imported into SPSS version 24 for analysis.

Measures
Characteristics of Pharmacy and Respondents
The following four measures describe both the pharmacies and respondents
generally. These include whether the pharmacy is rural or urban; whether it is a chain or
private pharmacy; the perceived gender of the respondent; and the respondent’s reported
job title. Detailed descriptions of these measures are listed below.
1. Urban/Rural/ Appalachian
As outlined above, pharmacies were designated as either rural, urban, or
Appalachian in the dataset. Urban was coded as “1”; rural was coded as “2” and
Appalachian was coded as “3” in the final SPSS dataset. Because of the similarities
between the rural and Appalachian samples, this variable was also recoded into
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Urban/Non-Urban where the pharmacies from Louisville, Lexington and Bowling Green
were coded as “2” and labeled “Urban” and the pharmacies in the Appalachian and Rural
samples were combined and coded as “1” for “Non-Urban”.
2. Chain or private
Each pharmacy contacted is classified a chain pharmacy (e.g., Walgreens, CVS)
or as a private pharmacy as reflected in the sampling frame of Kentucky pharmacies
provided by the Kentucky Board of Pharmacy. In the dataset, chain pharmacies are coded
as “1” and private pharmacies are coded as “2”.
3. Perceived Gender
This measure noted the gender of the person interviewed at the pharmacy as
subjectively perceived by the caller. The caller was prepared to list each individual
answering the call as male, female, or indeterminate. However, all pharmacy employees
were subjectively perceived to be either very likely male (coded “1”) or very likely
female (coded “0”).
4. Reported Job Title
Near the end of each interview, if the interviewee had not already offered their job
title or otherwise been clearly identified as the pharmacist, etc., the caller asked some
version of the question, “So are you the pharmacist?” Upon being asked this or with a
simple continuation of the question, almost all of the interviewees would readily offer
their job title. Interviewees were categorized as PHARMACIST, PHARM TECH,
PHARMACY INTERN, or CASHIER. Only 5 interviewees identified as anything other
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than a pharmacist or pharmacy technician, so these five were labeled “OTHER” and
coded as missing in the analysis.

Physical and Economic Accessibility of EC
The five measures included in this category describe the physical availability of
emergency contraception at the pharmacy as well as the cost. These include whether the
pharmacy carries EC; whether the respondent recommended another pharmacy if they did
not carry EC; whether or not they had EC in stock; the product’s location in the store and
the cost of the product.
1. Pharmacy Carries EC
The caller asked in each interview, “Do you carry the morning after pill?” Any
answer indicating that the pharmacy usually stocked Plan B or any other generic oral
Emergency Contraceptive was classified as a YES (coded “1”; NO coded “0”) even if the
pharmacy was out of stock at the time of the call.
2. If No, Recommends Other Pharmacy
The caller asked “Do you know where I can get it?” This measure was recorded
as a YES (coded “1”; NO coded “0”) only if the pharmacy employee directed the caller
one or more other specific pharmacy by name as a likely source of EC.
3. Has in Stock Presently
If told that the pharmacy did carry “the morning after pill,” the caller next asked,
“Can I get it right now?” to determine that the pharmacy both normally stocked EC and
had it in stock at the time of the call. YES was coded 1 and NO was coded 0.
4. Location within Store
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In each interview the caller asked were in the store the product was located.
Answers such as “behind the counter,” or “here in the pharmacy,” were coded as
BEHIND THE PHARMACY COUNTER (Coded “1”). If the pharmacy employee stated
that the EC was in a locked case this was recorded as LOCKED ON SALES FLOOR
(coded “2”). If the product was stated to be “in the store,” “over the counter,” on a given
aisle or in a given department, but not noted to be in a locked case this was coded as
SALES FLOOR (coded “3”).
5. Cost of EC
The caller asked each respondent for the price of the EC product available at the time
of the call. The given dollar amount was recorded as stated. If the respondent gave the
prices of several options, the dollar amount of the cheapest product was recorded.

Pharmacy Staff Knowledge of EC
To determine the likelihood of an adolescent receiving accurate answers to
questions about emergency contraception, five knowledge-based questions were asked
during each interview. These questions assessed if a pharmacy staff member knew
whether or not a prescription was required for purchase; if the caller needed to bring an
adult to purchase the product; if they knew the timeframe for efficacy of EC; if they knew
how effective EC is for preventing pregnancy; and whether EC is an abortifacient. If the
staff member voluntarily stated the percentage of efficacy they believed to be correct, that
was recorded as well. Also, an overall knowledge scale was developed and included in
this measurement category.
1. Requires Prescription
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The caller asked “Do I need a prescription?” YES (coded “1”; NO coded “0”) is
recorded for this measure if the pharmacy employee indicated that a prescription was
required for any purchase of EC or if the employee initially indicated that no prescription
was required but amended that answer upon hearing that the caller is 15.
This variable was recoded into a variable that indicated whether the employee’s
response was correct (consistent with the literature and current laws) or incorrect.
Incorrect answers included all answers that indicated the caller needed a prescription and
any uncertain answers. Incorrect answers were coded “0” and correct answers were coded
“1”.
2. Requires Adult to Purchase
The caller would state in each interview that she was 15 and ask “so do I need to
bring my mom or someone...older?” Any answer indicating that the caller must, should,
or “would probably need to” bring a parent or at least an adult age 18 was recorded as a
YES (coded “1”; NO coded “0”).
This variable was recoded into a variable that indicated whether the employee’s
response was correct (consistent with the literature and current laws) or incorrect.
Incorrect answers included all answers that indicated the caller needed to bring an adult
and any uncertain answers. Incorrect answers were coded “0” and correct answers were
coded “1”.
3. Stated efficacy timeframe (in hours)
The caller asked “How long after sex does it work?” Most pharmacy staff
answered in a number of hours; most commonly 24, 48, or 72. Any specific number of
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hours was recorded. If the pharmacy employee answered a range (e.g., “24 to 48 hours”)
the higher number was recorded. If the answer was unclear or the pharmacy employee
declined to provide an answer, it was coded as “99” in the dataset and excluded from
final analysis.
This variable was recoded into a variable that indicated whether the employee’s
response was correct (consistent with the literature and current laws) or incorrect.
Incorrect answers included all answers that underestimated or overestimated the efficacy
timeframe (more or less than 72 hours after unprotected sex) as well as any uncertain
answers. Incorrect answers were coded “0” and correct answers were coded “1”.
4. Perceived Assurance of Efficacy
This measure reflected the answers to the caller’s question “Will it work for
sure?” The answers varied widely and were assigned as affirming a very high likelihood
of preventing pregnancy YES (coded “1”) if the pharmacy employee offered such
answers as, “yes,” “definitely,” “absolutely,” “it’s really effective,” “it’s really good,”
etc., or if the pharmacy employee offered a percent chance of preventing pregnancy of
95% or higher. Numerical answers lower than 95% or such as “no,” “nothing’s
guaranteed,” “it’s not 100%”, etc. were coded as NO (coded “0’).
This variable was recoded into a variable that indicated whether the employee’s
response was correct (consistent with the literature) or incorrect. Incorrect answers
included all answers that indicated certainty/near certainty of preventing pregnancy and
any answers that indicated the employee did not know the efficacy (e.g., “I don’t know”
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or “I’m not sure”). Incorrect answers were coded “0” and correct answers were coded
“1”.
5. Believed % Efficacy if Stated
Pharmacy staff members were never asked to provide a percent chance of EC
preventing pregnancy, but many offered a percent chance as part of their answer to the
question, “Will it work for sure?” Additionally, if the caller were told that the EC would
“absolutely” or “definitely” work, this was recorded as an answer of 100%, since
assigning this numerical value would not require subjective evaluation. Any 15-year-old
caller would reasonably believe such unequivocal terms to mean that EC is literally 100%
effective.
6. Stated EC is abortion
Each interview included the question, “So is it the same like going and getting an
abortion?” Answers were coded as NO (coded “0”), YES (coded “1”), or UNCLEAR.
The answers “no,” “it’s not like that,” “I don’t think so,” etc. were coded as NO. Answers
such as “yes,” “I would say so,” or “anytime you interfere with the pregnancy that’s
basically an abortion,” were coded as YES. All others were coded as UNCLEAR,
including declining to answer. Unclear answers were coded as missing and removed from
analysis.
This variable was recoded into a variable that indicated whether the employee’s
response was correct (consistent with the literature) or incorrect. Incorrect answers
included all answers that indicated emergency contraception is an abortifacient as well as
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any unclear or unsure answers. Incorrect answers were coded “0” and correct answers
were coded “1”.
7. Overall Knowledge Scale
As previously stated, the answers to the following questions were recoded to
indicate whether an interviewee’s responses were correct or incorrect:
1.

Do I need a prescription?

2.

Do I need to bring my mom or someone older?

3.

How long after sex does it work?

4.

Will it work for sure?

5.

Is it the same like going and having an abortion?

Each correct answer was coded as “1” and each incorrect answer was coded as
“0”. An overall correct answer scale was created by summing these variables. The scale
ranged from 0-5, with higher scores indicating a greater number of correct responses.

Attitudes of Pharmacy Staff as Perceived by Caller
These measures are subjective scorings of the attitudes of the person interviewed.
The caller ranked each final interviewee on intended helpfulness, apparent discomfort,
and perceptibly judgmental attitude. Unhelpfulness is ranked on a scale of 1 through 5,
with 1 being very helpful and 5 being very unhelpful. Incorrect information is not held
against the interviewee in this measure, as it is strictly a measure of their apparent intent
to provide assistance to the caller. Apparent discomfort was measured on a scale of 1
through 5, with 1 indicating no discomfort and 5 indicating extreme discomfort.
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Recognized indicators of discomfort included offering equivocal answers, declining to
answer, taking a long time to answer, etc. Perceived judgmental attitude was measured on
a scale of 1 through 5, with 1 representing no perceptible judgmental attitude and 5
representing an extremely judgmental attitude. Indicators of a perceptibly judgmental
attitude included audible exclamations, assuming an angry tone of voice, or hanging up
on the caller after hearing her age or when asked questions about abortion. These three
measures were summed and averaged to create a 5-point overall negative attitude scale
which was found to have good internal consistency (α=.83).
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Chapter 4
RESULTS

Descriptive Results
To understand the accessibility of emergency contraception in Kentucky
generally, frequencies and percentages of the variables were obtained using SPSS version
24. The descriptive results of the sample are detailed below.

Characteristics of Pharmacy and Respondents
Over half (57%) of the pharmacies included in the study were urban while 43%
were rural. Chain pharmacies made up 49% of the sample, while private pharmacies
accounted for 51% of the sample. Of those who were interviewed, 76% were perceived to
be female while just 24% were perceived as male. When asked their job titles, 51% of
those interviewed identified themselves as pharmacists, 44% said they were pharmacy
technicians, and 5% reported some other job title. Results are displayed in Table 1.
Table 1: Descriptive Characteristics of Pharmacies and Respondents

Frequency

%

Urban/Non-Urban (n=220)
Urban 125
Non-Urban 95

56.8
43.2

Chain 108
Private 112

49.1
50.9

Female 167
Male 53

75.9
24.1

Chain/Private (n=220)

Perceived Gender (n=220)

Reported Job Title (N=103)
Pharmacist 53
Pharm Tech 45
Other 5

51.46
43.69
4.85

Physical and Economic Accessibility of Emergency Contraception
Of the pharmacies called, just over half regularly carried emergency contraception
(51%). Of those respondents from the 49% of pharmacies that did not carry EC, 61%
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were able to recommend another pharmacy that carried EC. Of those that carried EC,
93% had it in stock at the time of the call. The average cost of EC at these pharmacies
was $42.69 (SD= $8.39). About half (51%) of the pharmacies responded that EC was
available at that time on their sales floor. Over a quarter (28%) reported that EC was
located either behind the pharmacy counter or locked on the sales floor. Results are
reported in Table 4 below.

Table 2: Descriptive Information of Physical and Economic Accessibility to Over-the-Counter Emergency Contraception

Frequency

%

Pharmacy Carries EC (N=220)
Yes 111
No 109

50.5
49.5

Yes 69
No 41

62.7
37.3

Yes 103
No 8

92.8
7.2

Recommends other Pharm if no (N=110)

In Stock Today (N=111)

Location in the Store (N=103)
Behind Pharmacy Counter
Locked on Sales Floor
On Sales Floor
No Answer/Not Sure

18
11
53
21
Mean

SD

17.48
10.68
51.46
20.38
Min

Max

$8.39

$24.00

$70.00

Reported Cost of EC (N=103)
Cost $42.69

Pharmacy Staff Knowledge of Emergency Contraception
Most (95%) of the respondents correctly stated that EC was available without a
prescription. Although 62% of the respondents correctly stated that the 15-year-old caller
did not need an adult to purchase EC, 39% responded to this question incorrectly. Over a
quarter (28%) of respondents did not give the correct answer to the question “how long
after sex does it work?” Most (55%) of respondents over-estimated how effective EC is
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for preventing pregnancy. Around one-in-five of those called (22%) either reported that
using EC is the same as having an abortion or indicated they were unsure. The average
score on the Overall Knowledge Scale was 3.4 (SD= 1.19) with a minimum score of 0
(all answers incorrect) and a maximum score of 5 (all answers correct). Results are
displayed in Table 3 below.
Table 3: Descriptive Information of Pharmacy Staff Knowledge about Over-the-Counter Emergency Contraception

Frequency

%

Need Prescription (N=103)
Yes 5
No 98

4.9
95.1

Need Adult to Purchase (N=103)
Yes
No
Don’t Know/ Not Sure
Correct Answer: Efficacy Timeframe (N=103)
Correct
Incorrect
Correct Answer: Efficacy Assurance (N=77)
Correct
Incorrect
EC is the same as Having Abortion (N=102)
Yes
No
Unknown/Unsure

38
63
2

36.9
61.7
1.9

74
29

71.84
28.16

35
42

45.5
54.5

19
80
3
Mean

SD

18.6
78.4
2.9
Min

Max

1.19

0

5

Overall EC Knowledge (N=103)
Increases= More correct answers 3.40

Perceived Attitudes of Pharmacy Staff
The measure of perceived unhelpfulness ranged from 1 to 5 with higher scores
indicating greater unhelpfulness. The mean score on this measure was 2.38 (SD=1.31)
with a minimum score of 1 and maximum score of 5. The perceived discomfort measure
also ranged from 1 to 5 with increases indicating greater discomfort. The mean
discomfort score was 1.17 (SD=1.19) with a minimum score of 1 and maximum score of
4. The perceived judgmental attitude measure again included ratings ranging from 1 to 5.
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The mean value for this measure was 1.67 (SD=1.12) with a minimum score of 1 and a
maximum score of 4. After the previous three measures were summed and averaged to
create a 5-point overall negative attitude scale, the mean value was 1.67 (SD= 1.12) with
a minimum score of 1 and a maximum of 4. Results are displayed in Table 4 below.
Table 4: Descriptive Information Perceived Attitudes of Pharmacy Staff

Perceived Unhelpfulness (N=103)
Increases= Increasingly Unhelpful
Perceived Discomfort (N=103)
Increases= Increasingly Uncomfortable
Perceived Judgmental (N=103)
Increases= Increasingly Judgmental
Perceived Negative Attitude (N=103)
Increases= Increasingly Negative Attitude

Mean

SD

Min

Max

2.38

1.31

1

5

1.17

1.19

1

4

1.67

1.12

1

4

1.92

1.04

1

5

Inferential Results
To explore the data for any relevant differences in affordability, in physical
accessibility, in pharmacy staff knowledge, and in pharmacy staff attitudes based on
whether a pharmacy was chain or private and whether a pharmacy was rural or urban,
chi-square and independent sample T-test analyses have been conducted using SPSS
version 24. Similar analyses were conducted to test if there were differences in all the
dependent variables based on whether the respondent was a pharmacist or pharmacy
technician. After this, four regression models were conducted to test specific hypotheses.
A sequential logistic regression analysis was conducted to determine if availability of EC
could be predicted based on whether the pharmacy was rural or urban or if it was chain or
private. An additional logistic regression analysis was conducted to determine if the
likelihood of a pharmacy being chain or private could be predicted based on whether it is
in a rural or urban setting. Then, two sequential linear regression analyses were
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conducted to determine if chain/private or rural/urban pharmacy statuses were significant
predictors of pharmacy staff knowledge about emergency contraception and perceived
negative attitude towards the conversation.

Associations/Differences between Rural and Urban Pharmacies
Chain pharmacies were more likely to be found in urban areas (χ2= 23.06;
p=.000). Around 63% of urban pharmacies were chain pharmacies while just 30% of the
rural pharmacies were pharmacy chains. Also significantly associated was the likelihood
of a pharmacy carrying EC; 61% of urban pharmacies carried EC while just 37% of rural
pharmacies carried it (χ2= 12.36; p=.000). While only 1.4% of urban pharmacy staff
members said that a 15-year-old would need a prescription to purchase EC, 13% of rural
respondents reported that a prescription was necessary (χ2= 6.22; p=.013). Urban
pharmacy staff members were more likely to correctly know how long after sex EC
remained effective when compared to rural staff; 82% of urban respondents answered this
correctly while 63% of rural respondents gave a correct answer (χ2= 4.030; p=.045).
Similarly, urban pharmacy staff members were more likely to answer correctly when
asked “is this the same as going and having an abortion?” Of the rural respondents, 64%
answered this question correctly, while 93% of urban pharmacy staff responded correctly
(χ2= 11.85; p=.001). The difference in overall EC knowledge between rural and urban
pharmacies was significantly different (t= 3.07; p=.001). On average, urban staff scored
3.63 (SD=.956) on the 5-point knowledge scale. Rural staff scored 2.87 (SD=1.50) on
average. There was also a significant difference in overall negative attitude between these
two groups (t= 3.53; p=.008). The average score in perceived negative attitude among the
urban sample was 1.69 (SD=1.18). Among rural pharmacy staff, the average score was
2.44 (SD=.891). Results are displayed in Table 5.
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Table 5: Significant Associations/Differences Based on Urban/Rural Pharmacies

Chain/Private
Chain
Private
Pharmacy Carries EC
Yes
No
Need Prescription
Yes
No
Correct Answer:
Efficacy Timeframe
Correct
Incorrect
Correct Answer: EC is
the same as Having
Abortion
Correct
Incorrect
Perceived Negative
Attitude
(Higher Values=
Worse attitude)
Correct Answers Total
(Higher
values=Correct
Knowledge Answers)

f
79
46
f
76
49
f
1
71
f

Urban
%
63.2
36.8
%
60.8
39.2
%
1.4
98.6
%

f
29
66
f
35
60
f
4
27
f

Rural
%
30.5
69.5
%
36.8
63.2
%
12.9
87.1
%

Total
f
%
108 49.1
112 50.9
f
%
111 50.5
109 49.5
f
%
5
4.9
98
95.1
f
%

Test Stat

55
12
f

82.1
17.9
%

19
11
f

63.3
36.7
%

74
23
f

76.3
23.7
%

χ2=4.030*
(.045)

62
5
M

92.5
7.5
SD

18
10
M

64.3
35.7
SD

80
15
M

84.2
15.8
SD

χ2=11.85***
(.001)

1.69

1.18

2.44

.891

1.92 1.04

M
3.63

SD
.956

M
2.87

SD
1.50

M
SD
3.40 1.19

χ2=23.06***
(.000)
χ2=12.39***
(.000)
χ2=6.22*
(.013)

t =3.53**
(.008)
t =-3.07**
(.001)

Associations/Differences between Chain and Private Pharmacies
The likelihood of a pharmacy carrying EC was significantly associated with a
pharmacy’s designation as either chain or private. While 87% of chain pharmacies
carried EC, just 15% of private pharmacies carried it (χ2= 113.572; p=.000). Of those
private pharmacies that carried EC, over a third (35%) were out of stock at the time of the
phone call, whereas 2% of chain pharmacies reported that the product was not in stock
(χ2= 23.68; p=.000). Two percent of chain pharmacies told the caller that a prescription
was required to purchase EC; over a quarter of private pharmacies indicated that a
prescription was necessary (χ2= 13.40; p=.008). Similarly, chain pharmacies were much
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more likely than private pharmacies to correctly inform the caller that she did not need to
bring an adult, with 65% of chain pharmacies and 30% of private pharmacies responded
correctly (χ2= 4.74; p=.030). Private pharmacies were also more likely to indicate that EC
is equivalent to having an abortion; 44% of private and 13% of chain pharmacy staff
indicated that EC caused abortion (χ2= 6.14; p=.013). Overall knowledge of EC between
chain and private pharmacy staff was significantly different (t=-2.58; p=.011). On
average, chain staff scored 3.50 (SD=1.11) on the 5-point knowledge scale. Private staff
scored 2.55 (SD=1.51) on average. While EC knowledge was lower on average in private
pharmacies when compared to chain pharmacies, EC was reportedly around $7.46
cheaper at private pharmacies. The average cost of EC at private pharmacies was $36.05;
the average cost at chain pharmacies was $43.51(t= 2.88; p=.005). There was a
significant difference in overall negative attitude between these two groups (t= -2.13;
p=.006). The average score in perceived negative attitude among the chain sample was
1.83 (SD=.960). Among private pharmacy staff, the average score was 2.73 (SD=1.37).
Table 6 below outlines the results.
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Table 6: Significant Differences and Associations Based on Chain/Private Pharmacies

Pharmacy Carries EC

f
Yes 94
No 14
EC in Stock
f
Yes 92
No 2
Need Prescription
f
Yes 2
No 90
Correct Answer: Needs
f
Adult
Correct 60
Incorrect 32
Correct Answer: EC is the f
same as Having Abortion
Correct 75
Incorrect 11
Price
M
$43.51
Perceived Negative
Attitude
(Higher Values= Worse
attitude)
Correct Answers Total
(Higher values=More
Discomfort)

Chain
%
87.0
13.0
%
97.9
2.1
%
2.2
97.8
%

f
17
95
f
11
6
f
3
8
f

Private
%
15.2
84.7
%
64.7
35.3
%
27.3
72.7
%

Total
f
%
109
49.1
111
50.9
f
%
103
92.8
8
7.2
f
%
5
4.9
98
95.1
f
%

Test Stat
χ2=113.572***
(.000)
χ2=23.68***
(.000)
χ2=13.40**
(.008)

65.2
34.8
%

3
7
f

30.0
70.0
%

63
38
f

62.4
37.6
%

χ2=4.74*
(.030)

87.2
12.8
SD
$7.81

55.6
44.4
SD
$10.34

84.2
15.8
SD
$8.39

χ2=6.14*
(.013)

SD

80
15
M
$42.
69
M

M

SD

5
4
M
$36.
05
M

1.82

0.96

2.73

1.37

1.92

1.04

M
3.50

SD
1.11

M
2.55

SD
1.51

M
3.40

SD
1.19

t =2.88**
(.005)

SD
t =-2.13**
(.006)
t =-2.58**
(.011)

Associations/ Differences between Pharmacists and Pharmacy Technicians
The only significant difference between pharmacists and pharmacy technicians
was perceived gender. Of the pharmacists interviewed 47.1% were perceived to be male
and 52.8% were perceived as female. Of the pharmacy technicians, only 20% were
perceived as male while 80% were perceived to be female (χ2= 7.93; p=.005). There were
no other significant differences between pharmacists or pharmacy technicians, including
their responses to the knowledge-based questions. Results are displayed in Table 7 below.
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Table 7: Associations/Differences Based on Job Title

Pharmacist
Perceived Gender

f
Female 28
Male 25
Perceived Negative Attitude
M
(Higher Values= Worse 1.91
attitude)
Correct Answers Total
M
(Higher values=Correct 3.32
Knowledge Answers)

Pharm Tech

Total

%
52.8
47.1
SD
1.02

f
36
9
M
1.85

%
80
20
SD
.944

f
64
34
M
1.92

%
65.3
34.7
SD
1.04

SD
1.16

M
3.56

SD
1.18

M
3.40

SD
1.19

Test Stat
χ2=7.929**

(.005)
t =.269
(.787)
t =-.993
(.323)

Factors on Likelihood of Pharmacy Carrying Emergency Contraception
The null hypotheses for this analysis were:
H∅1= There will be no relationship between the likelihood of a pharmacy
carrying EC and whether a pharmacy was a chain or private while
accounting for other relevant factors.
H∅2= There will be no relationship between the likelihood of a pharmacy
carrying EC and whether a pharmacy was urban or rural while accounting
for other relevant factors.
The dependent variable in this model was whether a pharmacy regularly carried EC. The
independent variables of interest were “rural vs. urban” and “chain vs. private” pharmacy
status. Perceived gender was a control variable in this analysis.
In the control model, perceived gender was a significant predictor of whether a
pharmacy carries emergency contraception. Pharmacies where a male staff member
responded were over three times as likely to carry EC (OR=3.26; p=.001). This first
model was significant (χ2= 12.605, df=1; N=220; p=.000). Based on the pseudo-R
estimates, the control model accounted for between 6% (Cox & Snell R2= .057) and 8%
(Nagelkerke R2= .076) of the variance.
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The addition of the chain vs. private pharmacy variable in the second model,
perceived gender was no longer a significant factor. Holding gender constant, whether the
pharmacy was chain or private was a significant predictor of whether the pharmacy
carried EC. The odds of a pharmacy carrying EC are 97% lower when the pharmacy was
privately operated (OR= .028; p=.000). This model was also itself significant (χ2=
129.926, df=2; N=220; p=.000). Based on the pseudo-R estimates, the second model
accounted for between 45% (Cox & Snell R2= .446) and 60% (Nagelkerke R2= .595) of
the variance. This addition improved the model fit by 39-52%.
In the full model, the urban vs. rural variable was added, but it was not a
significant predictor. The chain vs. private pharmacy variable remains significant at about
the same level (OR= .027; p=.000). The full model was significant (χ2= 130.005, df=3;
N=220; p=.000). The addition of the urban vs. rural variable did not change the pseudo-R
estimates; and, therefore, did not significantly improve the model fit. Hence, we rejected
H∅1 but failed to reject H∅2. Results are reported in Table 8.
Table 8: Logistic Regression Results- Factors on Likelihood of Carrying EC

Variables

Model 1
Control Model
Odds Ratios

Perceived Gender 3.26**
Female= 0 (.343)
Male=1
Private Pharmacy -Chain= 1
Private=2

Model 2
Chain or Private
Odds Ratios
2.45
(.473)

Model 3
Urban or NonUrban
Odds Ratios
2.52
(.486)

.028***
(.393)

.027***
(.416)

-.887
Urban Pharmacy -(.426)
Non-Urban= 1
Urban=2
Standard errors are reported in parentheses; *p < .05; **p < .01; ***p <.001
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Urban or Non-Urban Location on Likelihood of Pharmacy Being Chain or
Private
The null hypothesis associated with this analysis was as follows:
H∅= There will be no relationship between the likelihood of a pharmacy
being chain or private and whether a pharmacy was in a rural or urban
setting.
The dependent variable in this model was whether a pharmacy is a chain or privately
operated and the only independent variable was whether a pharmacy was urban or nonurban/rural. In this model, the location of the pharmacy (rural vs. urban) was a significant
predictor of whether a pharmacy was privately operated or a chain. An urban pharmacy
was 74% less likely to be privately operated than a non-urban pharmacy (OR= .256;
p=.000). Model was significant (χ2= 23.542, df =1; N=220; p=.000). Based on the
pseudo-R estimates, the second model accounted for between 10% (Cox & Snell R2=
.101) and 14% (Nagelkerke R2= .135) of the variance. Given these results, H∅ was
rejected.

Factors on Pharmacy Staff Knowledge of Emergency Contraception
The null hypotheses associated with this analysis were as follows:
H∅1= There will be no relationship between the pharmacy staff knowledge
of EC and whether a pharmacy was a chain or private while accounting for
other relevant factors.
H∅2= There will be no relationship between the pharmacy staff knowledge
of EC and whether a pharmacy was urban or rural while accounting for
other relevant factors.
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The dependent variable in this model was the 5-point overall EC knowledge scale
described in the measurements above. The independent variables of interest were “rural
vs. urban” and “chain vs. private” pharmacy status. The control variables were perceived
gender and job title.
Neither control variable (perceived gender and job title) was a significant
predictor of pharmacy staff knowledge of EC in the control model. The second model
adds the “private vs. chain” pharmacy variable. With the inclusion of this variable, the
gender and job title were still not significant predictors. Whether a pharmacy was a chain
or private pharmacy was a significant predictor while controlling for gender and job title.
Pharmacy staff from private pharmacies were expected to score over half a point lower
on the overall knowledge scale (β= .637; p=.010). The third model added the “urban vs.
rural” variable. When this variable was included, whether a pharmacy was chain or
private was no longer a statistically significant predictor. However, whether a pharmacy
was located in a rural or urban area was a significant predictor of pharmacy staff
knowledge while controlling for gender, job title, and chain/private pharmacy status.
Pharmacy staff members from urban pharmacies were expected to score over half a point
higher on the overall knowledge scale when compared to staff members from rural
pharmacies (β=.608; p=.016).
The full model explains nearly 14% of the total variance (R2 = .136). This
indicated an improvement in model fit of nearly 13% when compared to the control
model (R2 = .012). When compared to the second model, the full model improved model
fit by around 6% (R2 = .080). The entire model was also significant (F=3.655; p=.008).
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Given these results H∅2 was rejected while we failed to reject H∅1. The results are
displayed in Table 9.
Table 9: Linear Regression Results- Factors on Overall Knowledge of EC

Variables

Model 1
Control Model
Unstandardized
Coefficients

Model 2
Chain or Private
Unstandardized
Coefficients

Perceived Gender
Female= 0
Male=1
Reported Job
Title
Pharmacist= 1
Pharm Tech=2

.121
(.296)

-.020
(.292)

Model 3
Urban or NonUrban
Unstandardized
Coefficients
-.140
(.288)

.269
(.253)

.319
(.246)

.326
(.240)

-.637**
(.241)

-.465
(.245)

Private Pharmacy -Chain= 1
Private=2

-.608*
Urban Pharmacy -(.248)
Non-Urban= 1
Urban=2
Standard errors are reported in parentheses; *p < .05; **p < .01; ***p <.001

Factors on Perceived Negative Attitude of Pharmacy Staff
The null hypotheses associated with this analysis were as follows:
H∅1= There will be no relationship between the negative attitude of the
pharmacy staff and whether a pharmacy was a chain or private while
accounting for other relevant factors.
H∅2= There will be no relationship between the negative attitude of the
pharmacy staff and whether a pharmacy was urban or rural while
accounting for other relevant factors.
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The dependent variable in this model was the 5-point Perceived Negative Attitude scale
described in the measurements above. Again, the independent variables of interest were
“rural vs. urban” and “chain vs. private” pharmacy status. The control variables were
perceived gender and job title.
Neither control variable (perceived gender and job title) was a significant
predictor of pharmacy staff attitudes in this first model. The second model added the
“private vs. chain” pharmacy variable. Neither the new variable nor the original control
variables were significant in this second model. The third model added the “urban vs.
rural” variable, which was a significant predictor of perceived attitudes of the pharmacy
staff. Pharmacy staff from urban areas were expected to have a score over a half point
lower on the negative attitude scale than those from rural areas (β= -.622; p= .007).
Interestingly, the inclusion of this variable also rendered the perceived gender variable
significant. Perceived male members of pharmacy staff were expected to have a negative
attitude score of nearly a half point higher than those perceived female (β= -.464; p=
.028).
The full model explained nearly 13% of the total variance (R2 = .129). This
indicated an improvement in model fit of nearly 9% when compared to the control model
(R2 = .035). When compared to the second model, the full model improved model fit by
around 7% (R2 = .057). The entire model was also significant (F=3.438; p=.011). Given
these results H∅2 was rejected while we failed to reject H∅1.The results are displayed in
Table 10.
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Table 10: Linear Regression Results- Factors on Perceived Negative Attitude of Pharmacy Staff

Variables

Model 1
Control Model
Unstandardized
Coefficients
Perceived Gender .393
Female= 0 (.216)
Male=1
Reported Job Title .053
Pharmacist= 1 (.206)
Pharm Tech=2

Model 2
Chain or Private
Unstandardized
Coefficients
.409
(.215)

Model 3
Urban or Non-Urban
Unstandardized
Coefficients
.464*
(.208)

.018
(.246)

.003
(.240)

Private Pharmacy -Chain= 1
Private=2

509
(.342)

.183
(.351)

---.622**
Urban Pharmacy
(.244)
Non-Urban= 1
Urban=2
Standard errors are reported in parentheses; *p < .05; **p < .01; ***p <.001

Additional Comments
Occasionally during the interviews, a respondent would provide anecdotal
information which would be recorded. The following is a list of these details:
1. 5 respondents offered to order EC when it was not in stock
2. 4 mentioned the local health department or a free clinic as a source of free EC
3. 3 suggested talking to a doctor instead of calling the pharmacy
4. 2 indicated low-demand as the reason they do not carry EC (“It expired on the
shelf’)
5. 1 refused to check the price
6. 1 recommended an out-of-county pharmacy
7. 1 told the caller that insurance may cover it
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8. 1 recommended that the caller seek long-term birth control because EC is “a
backup method”
After asking the question about whether EC is the same as having an abortion,
many respondents would explain how EC works or offer other comments. The following
list details these remarks.
1. 6 respondents correctly indicated that it will not harm an existing pregnancy
2. 7 incorrectly indicated that it could potentially harm an existing pregnancy
and/or cause abortion
3. 3 respondents correctly indicated that it blocks fertilization
4. 2 correctly indicated that it prevents ovulation
5. 1 indicated that it triggers menstruation
6. 1 said “it prevents the baby from forming”
7. 1 said “it’s not abortion but I don’t know how it works”
8. 2 verbally refused to answer this question
9. 7 hung up when asked this question
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Chapter 5
DISCUSSION AND RECOMMENDATIONS
As demonstrated in this study, adolescents seeking information about over-thecounter emergency contraception in Kentucky were likely to face many barriers.
Although barriers to EC were found throughout the state, they were especially
concentrated in rural areas. Prior research in other states has demonstrated rural
disparities in access to EC products and accurate information relating to emergency
contraception (Mackin & Clark, 2011; Samson et. al., 2013; Gaffaney et. al, 2015). This
study demonstrated that similar inequities between rural and urban areas exist in the state
of Kentucky.

Physical and Economic Barriers to Emergency Contraception
Nearly half of the pharmacies called did not carry EC at all. Further, over a third
of pharmacies that did not carry EC were not able to recommend an alternative provider.
Those pharmacies were more likely to be private, rural pharmacies. These results are
consistent with the 2013 Kansas “secret shopper” study (Samson et al., 2013) which
found that urban pharmacies were twice as likely to have EC available at the time of the
call as were those in rural areas. This study also found that chain or private pharmacy
status was a better predictor of EC availability than was rural or urban status alone.
Seven-in-ten private pharmacies surveyed did not stock over-the-counter EC, and the
choice of merchandise stocked at chain pharmacies is dictated by corporate policies
developed outside the state. Therefore, except for those pharmacies obligated by
company-wide policy to carry the product, most of the surveyed Kentucky pharmacies
opted not to carry it. The specific reasons for this practice are unidentified and beyond the
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scope of this research. Still, recognizing that there were differences between urban and
rural availability is imperative. The fact that an urban pharmacy was 74% less likely to be
privately-operated means that the lack of availability in private pharmacies affected those
in rural areas most.
About half of the surveyed pharmacies stored their EC in a manner that requires
an adolescent seeking EC to interact with an employee (either locked on the sales floor or
behind the pharmacy counter). Anxiety about having to discuss personal and potentially
embarrassing information with an unknown staff member has been determined to be a
deterrent for an adolescent (Gaffaney, et al., 2015). Per the data, chain pharmacies were
more likely to have EC available unlocked on the sales floor, and chain pharmacies are
concentrated mostly in urban areas. Again, rural Kentucky adolescents would face greater
barriers to obtaining the product.
The findings in this study demonstrated that EC price may also be a barrier for
teenagers in Kentucky. If paid out-of-pocket, the average cost of EC in the state is
$42.69, which is likely not affordable for most teenagers. However, EC in private
pharmacies was found to be $7.46 cheaper than EC in chain pharmacies. While $36.05,
the average cost of EC at private pharmacies stocking EC, may be more affordable, it is
important to note that most private pharmacies did not carry EC at all while chain
pharmacies were nearly twice as likely to stock it. As mentioned in prior research (e.g.,
Bell, Camacho, & Velasquez, 2014), the price of over-the-counter EC can be an
economic barrier to obtaining EC in a sufficiently timely manner.
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Pharmacy Staff-Associated Barriers to Emergency Contraception
Staff-associated barriers are those barriers that exist only as a result of
misinformation provided to the adolescent customer. These barriers may include lack of
knowledge on the part of pharmacy staff and/or attitudes of pharmacy staff which may
motivate them to prevent access to EC.

Barriers Created by Lack of Knowledge among Pharmacy Staff
In this study, the average negative attitude score was low, only 1.92 out of 5.
However, the overall knowledge average was 3.4 out of 5 indicating several gaps in
knowledge. Consistent with the literature, this finding indicated that an honest lack of
knowledge may be a greater barrier than attitudes against providing EC to adolescents.
Studies discussed in the literature review found pharmacy staff lack of knowledge to be a
significant barrier to timely access to EC among their clients. Wilkinson and colleagues
(2012) found that researchers acting as physicians needing information about age
restrictions to over-the-counter EC access were nearly as likely to have received the
wrong information as researchers pretending to be adolescents. This indicates that the
pharmacy staff members were truly uninformed rather than intentionally deceptive.
Of the Kentucky pharmacies interviewed for this study, 95% correctly stated that
no prescription was required, and only 38% incorrectly stated an age requirement.
However, 65% of those answering correctly were chain pharmacies, which are
concentrated in urban areas. Therefore, misinformation about age requirements more
heavily affects rural areas of the state. Previous research by Wilkerson and colleagues
(2012) and Orr and colleagues (2015) found that more than half of the pharmacies
included in their studies provided the incorrect age requirement for EC purchase without
a prescription.
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Over a quarter (28%) of sampled pharmacies in this study reported an incorrect
efficacy timeframe for EC (up to 72 hours) with 37% of rural pharmacies giving an
incorrect timeframe, compared to just 18% of urban pharmacies. Further, 55% incorrectly
stated how effective EC is, typically overestimating its efficacy, and only one pharmacy
recommended that the caller seek a long-term birth control method. These findings are
problematic as demonstrated in the literature. Baird and colleagues (2015) discussed how
improper use and overestimation of EC’s effectiveness leads to overreliance on EC as a
primary birth control method. Similarly, in their 2012 study of Utah women who used EC
more than once during the year, Melton, Stanford and Dewitt found that successfully
using EC once led repeat users to overestimate its effectiveness. If Kentucky pharmacy
staff workers are misleading their customers into misusing EC, they are contributing to
the problem of overreliance on a birth control method that can readily fail to prevent
pregnancy if not used in a timely and correct manner.
In 2011, Mackin and Clark found that 38% of surveyed Iowa pharmacists
believed that over-the-counter EC functioned as an abortifacient. Similarly, Richman and
colleagues (2012) found that 46% of Florida pharmacists who responded to their survey
believed that EC induced abortion. Compared to these previous findings, the rate at
which Kentucky pharmacy staff members told the interviewer that EC caused an abortion
was much lower: just over 1-in-5 (21.6%) gave this answer. While that is comparatively
better, the number still indicates that misinformation perpetuating the idea that over-thecounter EC functions as an abortifacient remains a concern. Whether this was simple a
misunderstanding or a moral objection on the part of the pharmacy staff member, the
issue needs to be addressed. Telling an adolescent client that EC can cause an abortion
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may inadvertently make the pill seem much more effective in preventing pregnancy than
it actually is, further contributing to the problem of overreliance.

Pharmacy Staff Attitudinal Barriers
The negative attitude scale was a 5-point scale based on subjective scorings of the
attitudes of the person interviewed. The perceived attitudes included in this measure were
unhelpfulness, discomfort, and judgmental nature. Overall, negative attitude scores were
low with an average of 1.92 out of 5. However, teenagers in rural areas are more likely to
encounter negative attitudes when seeking EC. The linear regression results indicated that
urban pharmacy staff members were expected to score more than half a point lower on
the 5-point scale than those in rural areas. On average, urban pharmacies scored 1.69 out
of 5 on perceived negative attitude; rural pharmacies scored 2.44 out of 5 on average.
This was in line with the findings of Richard, Kinzey, and Masters (2015) in their study
of rural pharmacist attitudes toward contraception in general. Most of the rural
pharmacists surveyed in that study demonstrated discomfort about providing over-thecounter access to contraception to their patients and many actively opposed the
prescription of contraceptives (Richard, Kinzey, and Masters, 2015). It is important to
note that, while the negative attitude average among the rural sample was significantly
higher than those in the urban sample, it was still lower than half. Although perceived
negative attitude is a recognized barrier for rural EC access, lack of knowledge among
the pharmacy staff likely plays a greater role and offers a more effective route for
intervention.

Pharmacy Technicians vs. Pharmacists
For the most part, counseling on EC was lacking in this study. For example,
higher body weight reduces the efficacy of over-the-counter EC and women should be
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advised to transition to a permanent form of birth control with higher efficacy (Cleland,
Raymond, Westley & Trussell, 2014). However, only one pharmacist in this study
recommended a long-term birth control and none mentioned the weight contraindication.
This is consistent with Young, Griffin, and Vest (2013) who that found that, despite their
pharmaceutical education, pharmacists are underprepared to counsel those seeking overthe-counter emergency contraception.
Young, Griffin and Vest (2013) found that just 25% of the 200 graduating
students from Midwestern University’s College of Pharmacy in the study felt confident in
counseling patients on EC use. The most common self-reported barrier in that study was
lack of knowledge. Of those interviewed in this study, 51.46% were pharmacists and
43.69% were pharmacy technicians with the remaining 4.85% being some “other”
professional. Because of their educational level, it is reasonable to expect a pharmacist to
answer the knowledge-based questions more accurately than a pharmacy technician.
However, this study found no difference in overall knowledge or negative attitudes
between pharmacists and pharmacy technicians.

Study Strengths
This research was the first effort to understand pharmacy-based barriers to
adolescent access to over-the-counter contraception through a simulated experience in the
state of Kentucky. Unlike survey research that would rely on adolescent’s self-reporting
their own experiences, this study allowed the researcher to witness the pharmacyadolescent interaction, reducing the risk of report bias. Additionally, only one researcher
made the phone calls included in this study. Therefore, there was a level of
standardization in that every respondent talked to the same person. This helped assure
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that believability of the phone call and the framing of the questions was generally
consistent.
Unlike other “secret shopper” studies conducted to determine a teen’s experience
while seeking over-the-counter EC in a pharmacy setting, this research utilized regression
analyses to control for other factors that could impact knowledge, attitudes, and EC
availability beyond “rural vs. urban” and “chain vs. private.” Additionally, this research
looked at the impact of pharmacy operation type. The inclusion of the “chain vs. private”
measure in addition to the “rural vs. urban” measure provided a better understanding of
what factors determine EC availability in a pharmacy. While past “secret shopper”
studies of this topic identified a disparity between urban and rural availability of overthe-counter EC (Gaffaney et al., 2015; Wilkinson et al., 2012), they did not control for
the influence of “chain vs. private” which may have confounded their results. Only one
previous survey on EC availability, conducted by Samson and colleagues (2013)
controlled for “chain vs. private,” but that survey, conducted in 2012 (before the 2013
regulatory change) was not a “secret shopper” study and did not control for any
characteristics of the respondent.

Study Limitations
The non-probability sampling technique of this study was one of its major
limitations. The number of counties chosen for the rural/Appalachian sample was
determined based on the affordability of obtaining the per-county list of registered
pharmacies from the Kentucky Board of Pharmacies. Due to limited time and resources,
the sample may not be representative of the entire state.

73

Since the interviews were semi-structured, questioning and responses were often
altered based on the unanticipated flow of conversation. Generally, the caller tried to
follow the script as written, but occasionally the interviewees’ responses or tone of voice
caused the researcher to ask questions differently due to such occurrences as emotional
arousal or simply because the interviewee offered answers to questions that were not yet
asked. Therefore, these interviews were not standardized although the same information
was sought during each one.
The questions assessing perceived negative attitudes were based on one
researcher’s perception of a respondent’s unhelpfulness, discomfort, and judgmental
nature. Hence, these measures were completely subjective and another researcher may
have perceived these conversations differently. Originally, the study design included
recording the audio of these interviews and having other researchers rate the
conversations based on these measures. However, the Institutional Review Board did not
approve of recording the interviews.
This research should be considered as justification for further investigation into
the distribution of pharmacy-based barriers to adolescent access to over-the-counter EC
in our state. This study added to the body of literature it this area and future research into
should work to overcome the study limitations outlined above.

Recommendations
The primary pharmacy staff-associated barrier identified in this research was lack
of knowledge. The research also revealed that, while barriers were evident throughout the
state, all measured barriers were more heavily concentrated in rural areas of Kentucky.
The following recommendations are based primarily on these findings.
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First, because of the time restricted nature of this product and the fact that it is
only to be used as a last resort, pharmacy staff should receive more training on how to
accurately and knowledgably counsel anyone seeking over-the-counter EC and how to
best discuss this topic with adolescent clients. Several studies have found that adequate
counseling in the pharmacy setting leads to proper EC use and better outcomes for both
pharmacy staff and clients. Ragland, Payakachat, and Stafford (2015) found that when
pharmacy students counseled female participants for just ten minutes on the basics of use
of and access to EC, the women immediately scored higher on tests measuring their
knowledge of EC. The follow-up tests conducted several months later also showed
significantly higher scores in EC knowledge, demonstrating that a minimal 10-minute
educational exercise a pharmacy setting can lead to an immediate increase in
understanding of EC and continued retention of this knowledge. Batra, Aquilino, and
Farris (2015) evaluated pharmacy staff of 55 pharmacies that had all participated in
online education intervention aimed at demonstrating what they can do as healthcare
professionals to decrease unplanned pregnancy. After intervention, the authors found that
90% of participating staff reported more confidence in discussing contraceptives because
of the intervention and wanted to prioritize the topic. Young, Griffin, and Vest (2013)
studied two hundred third-year pharmacy students who participated in hands-on skits to
practice emergency contraceptive counseling. Prior to the workshop, only 25% of the
pharmacy students reported confidence in counseling patients on EC use. Following
participation in the exercise, 58.8% reported confidence in their counseling EC ability.
Given that prior evidence supports the efficacy of pharmacy-based counseling and that
the pharmacy staff are the experts available at the point of purchase, interventions to
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improve their ability to adequately counsel anyone seeking over-the-counter EC as well
as teenagers specifically should be developed and implemented throughout the state and
especially in rural regions.
Second, the public generally should be better informed about the proper use of
over-the-counter EC, the current lack of age restriction, and general facts about how it
functions and its efficacy. Devine (2012), seeking to explain why increased access to
over-the-counter EC did not result in a decrease in unintended pregnancies, argued that
lack of effectiveness to a combination of lack of awareness of the nature of EC and its
over-the-counter status, the incorrect belief that it is an abortifacient, privacy concerns,
and concerns over adverse health effects among the general public. Baird and colleagues
(2015) argued that in addition to the need for greater public awareness of and access to
emergency contraception, public health interventions need to aim at ensuring that women
who use EC will transition successfully afterwards to regular, more effective birth control
methods and to prevent overreliance on EC. Melton, Stanford, and Dewitt (2012) studied
women who had used EC more than twice in the year to better understand overreliance.
They found that most repeat users overestimated the efficacy of the products. The authors
asserted that women who repeatedly use EC successfully likely overestimate its
effectiveness. Efforts to increase access must also avoid inducing dependence on EC as
more than a backup method of contraception. Therefore, along with removing
accessibility barriers to over-the-counter EC, it is the responsibility of the public health
system to assure that as many women as possible receive accurate information about
proper use of EC. This goal may be best achieved via a social marketing or mass media
campaign implemented throughout the state of Kentucky and in rural areas specifically.
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In addition to creating a mass public health education campaign to increase
general knowledge of the proper use of EC, the public health system should better
advertise the fact that, in the state of Kentucky, emergency birth control is offered
through health department clinics free of charge in addition to other family planning
services (Kentucky Cabinet for Health and Family Services, 2015). While hours and
locations of the health departments may pose barriers for adolescents who lack
transportation or who are attending school, for those who can get to the health
department, it removes the financial burden and includes accurate EC counseling and
referrals to other services such as those providing long-term birth control and STI testing
(Kentucky Cabinet for Health and Family Services, 2015).
Third, adolescents should have access to accurate knowledge about their
reproductive health and about contraception generally. A significant problem facing teens
is a lack of reproductive education. The number of American female adolescents
receiving no formal instruction in school about birth control methods rose to 26% as of
2013 (Guttmacher Institute, 2016d). This lack of education is most concentrated in rural
America: as of 2013 only 48% of adolescent females in rural counties were receiving
formal education on birth control methods and in 2014, only 35% of high schools
reported that they included proper condom use in their reproductive health curriculum
(Guttmacher Institute, 2016d). A 2011 study by Kathrin Stanger-Hall and David W. Hall
found a high correlation between those states with school curricula requiring or
promoting abstinence as the only safer-sex option and those states with higher teen
pregnancy and birth rates. Even when controlled for socio-economic status and race, the
study found that states which adopted more comprehensive sex-education programs had
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lower rates of unintended teen pregnancy while those providing abstinence-only
education had the highest rates of unintended teen pregnancy (Stanger-Hall & Hall,
2011). While this type of intervention would likely face social opposition in the areas of
our state that are most affected by teenage pregnancy, formal education on reproductive
health, safe sex, and contraception, including education on the proper use of over-thecounter EC, is one of the most effective ways for preventing unintended pregnancy and
STIs among teenagers (Stanger-Hall & Hall, 2011).
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Chapter 6
CONCLUSION
It is critical that every individual receive accurate information that allows them to
make informed decisions about their own body and health, including reproductive health.
This includes adolescents, who are among the most at-risk and least advantaged members
of our society. Adolescents typically lack the education, the financial resources, and the
personal freedom needed for self-determination. Yet the reproductive decisions they
make or have made for them may follow them and determine the course of the rest of
their lives. The limited contraceptive options available to adolescents may become even
more restricted. Given the present precarious nature of reproductive healthcare funding
and availability, Emergency Contraception has never been a more important tool for
those members of our society who have the least access to contraceptive options.
Therefore, those who are regarded as experts within the pharmacy should be informed
and empowered to meet their responsibility of providing effective counseling to clients
seeking over-the-counter EC.
The recommendations offered in this thesis are consistent with the reproductive
health goals set forth by Healthy People 2020 plan and Public Health 3.0. One of the
Healthy People objectives for family planning is to lower unintended pregnancy by 10%
by 2020. This objective falls within the overall goal of improving pregnancy planning
and spacing and preventing unintended pregnancy generally (HHS, 2014). Public Health
3.0, building on the work of Healthy People 2020, calls on public health practitioners to
work across sectors and advocate for public health policies and programs that promote
health equity by directly affecting the social determinants of health. Education is one of
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the key social determinants identified by Public Health 3.0 as needing greater attention by
the public health system (HHS, 2016). Since unintended pregnancy is correlated with
lower educational attainment (Guttmacher Institute, 2016a), advocating for better
reproductive and contraceptive education for both adolescents and the public at large can
contribute to improving overall educational attainment, especially among at-risk
populations. Efforts to rescind the reproductive options guaranteed under the Patient
Protection and Affordable Care Act, to defund many reproductive healthcare providers,
and to allow employers religious exemptions from contraceptive coverage will, if
realized, frustrate plans to increase contraceptive access, to reduce unintended
pregnancies, and to achieve health equity on this front.
The results and recommendations presented herein represent a timely contribution
to the effort to understand how better to make EC available to the public, to inform those
seeking EC of its proper usage, and to continue to advance the public health interests of
the American people in the face of even greater adversity than previously expected.
This thesis successfully answered each of the five research questions set forth in
the Purpose of the Study. In summary, analysis of the collected data revealed that:
1. Yes, there were differences in/associations between affordability, physical
accessibility, pharmacy staff knowledge and pharmacy staff attitudes based on
whether a pharmacy is rural or urban. These differences were demonstrated
via the preliminary analyses and offer insight into the specific disparities
between the urban and rural Kentucky pharmacies in the survey.
2. Yes, there were differences in/associations between affordability, physical
accessibility, pharmacy staff knowledge and pharmacy staff attitudes based on
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whether a pharmacy is chain or privately owned. Again, these differences
were discovered initially through the preliminary analyses. While the
differences based on chain or privately-owned status were themselves
informative, the fact that urban pharmacies were 74% less likely to be
privately-owned and that chain pharmacies performed better on nearly every
measure further revealed the inequities faced by those in rural parts of the
state.
3. Yes, factors such as whether a pharmacy was chain or privately operated or
whether it was urban or rural did in fact predict a pharmacy’s likelihood of
carrying EC. While initially it seemed that “urban or rural” was a significant
factor in whether the pharmacy carried over-the-counter EC, the final model
demonstrated that whether a pharmacy was a chain or privately owned was a
better predictor of whether the pharmacy carries the product.
4. Yes, factors such as whether a pharmacy was chain or privately operated or
whether it was urban or rural did predict the level of EC knowledge among
pharmacy staff. Here it seemed initially that the chain or private status of a
pharmacy played a role in the overall knowledge level of its staff. However,
the final model showed that, in fact, rural or urban location was a better
predictor of overall EC knowledge.
5. Yes, factors such as whether a pharmacy was chain or privately operated or
whether it was urban or rural did predict the level of negative attitudes
demonstrated by pharmacy staff. As with question four, in the first model the
chain or private status of a pharmacy appeared to play a role in the staff’s

81

level of negative attitudes. However, the final model showed that, in fact, rural
or urban location was a better predictor of overall negative attitudes as well.
Still, it is important to recall that this measure was subjective as mentioned in
the study limitations section of this thesis.
By answering the selected research questions, this thesis made three distinct contributions
to the field of knowledge in public health.
First, this thesis represents the first time that data on the availability of over-thecounter EC to adolescents in the state of Kentucky has been collected and presented.
Indeed, the relevant literature reveals that extensive collection and analysis of data
derived from interactions which simulated the experience of an adolescent seeking EC
have been conducted in only a few other states. The addition of this unique data and its
analysis to the literature is not only useful for further study of over-the-counter
Emergency Contraception accessibility in Kentucky pharmacies and for use in the design
of public health interventions within the state; it also serves to increase the understanding
of over-the-counter Emergency Contraception access nationwide when added to the
extant literature on EC access in other states.
Second, this thesis added to the literature consideration of a factor not accounted
for in other “secret shopper” studies of barriers to emergency contraception access;
namely, the chain or private ownership of the pharmacies surveyed. This thesis has
identified chain vs. private ownership as the foremost determining factor in whether a
pharmacy carries over-the-counter EC. It is likely that the corporate policies of the chain
pharmacies obligated them to offer over-the-counter EC. Therefore, this study found that
when a pharmacy was not obligated by policy to carry the product, most of the surveyed
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Kentucky pharmacies elected to not carry it. However, many factors beyond the scope of
this thesis may contribute to this, such as differences in pharmacist and staff education or
employer provided training, differences in religious and other beliefs, the effect of an
urban or rural environment on those beliefs, financial burdens faced by the private
pharmacies, and so on. In any case, the role of chain vs. private ownership should be
included in any further research into pharmacy-based barriers to EC access, and should
also be considered in the planning of future public health policy and interventions
regarding over-the-counter Emergency Contraception access.
Third, this thesis demonstrated that barriers to over-the-counter Emergency
Contraception access, while prevalent across Kentucky, were much higher in the state’s
rural counties. As previously stated, the greatest factor in predicting that a pharmacy
would not carry EC was shown to be private ownership. Seven-in-ten of Kentucky’s rural
pharmacies are privately operated, and private pharmacies were only about half as likely
to carry EC as are chain pharmacies, regardless of urban or rural setting. Given that chain
pharmacies were concentrated in urban counties, the state’s rural population has limited
access to chain pharmacies and relies primarily on private pharmacies. Thus, many small
population centers may have no local pharmacy access to EC at all.
In addition to the greater likelihood of rural pharmacies being private and,
therefore, less likely to carry Emergency Contraception, this thesis also revealed that, on
average, rural pharmacy staff in the sample were less helpful when asked for information
about EC, more judgmental of a perceived adolescent asking for EC, more uncomfortable
discussing EC with an adolescent, less knowledgeable of the proper use, efficacy, and
legal status of over-the-counter EC than their urban peers, and less likely to be able to
83

refer the caller to another pharmacy. The data also revealed the average cost of EC at
private pharmacies that did carry EC to be lower than at chain stores; however, this
advantage would be of no benefit to most rural residents of Kentucky due to the low
number of private, rural pharmacies stocking EC.
In summary, this thesis has identified the key factors determining adolescent
barriers to over-the-counter Emergency Contraception in Kentucky pharmacies and has
determined the relative importance of those factors. This thesis has also provided
previously unavailable data and analysis which may be used to support future research on
access to EC and public health interventions within Kentucky and beyond. It has
provided evidence of the existence of greater barriers to EC access in Kentucky’s rural
pharmacies. It has demonstrated that among the sampled pharmacies, the private
ownership of a pharmacy was more determinative of likelihood of carrying EC that its
rural location and has suggested this as an avenue of further inquiry. Lastly, this thesis
has provided recommendations which, if implemented, will increase access to and the
effective use of over-the-counter EC. In so doing, this thesis has not only substantively
contributed to the literature on adolescent Emergency Contraception but has contributed
to fulfilling the responsibility of Public Health to promote the reproductive health of all
individuals and, specifically, to advocate for those least empowered to advocate for their
own reproductive rights.
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Appendices
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Appendix I: Flow Chart of Survey Instrument

The following chart is designed to outline the flow of conversation during the semistructured interviews. The green arrows indicate “yes answers; the red arrows indicate
“no” answers; and black arrows illustrate the conversational flow when the question will
not elicit a yes or no response.
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Okay. Do you carry the
morning after pill?

Can you
recommend a
pharmacy that
would have it?

Can I get it now?

Do I need a
prescription?

Okay, so I’m 15. Do I
need to bring my mom
or someone older…?

How long after sex
will it work?

Will it work for
sure?

Is this the same like
going and getting
an abortion?

Where can I find it
in your store?

Figure 1: Structured Interview Flow Chart

How much is it?

So are you the
pharmacist or a tech
or something?
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Call end

Appendix II: Significant Differences/ Associations Between Urban and
Rural Pharmacies

Chain and Private Pharmacies by Geographic
location
69.5%
63.2%
50.9%

49.1%
36.8%
30.5%

URBAN

RURAL
Chain

TOTAL

Private

Does the Pharmacy Stock EC?
63.2%

60.8%

50.5%
39.2%

URBAN

49.5%

36.8%

RURAL
Yes
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TOTAL
No

Need a Perscription to Purchase?

98.6%

95.1%
80.0%

1.4%

12.9%
URBAN

4.9%
RURAL
Yes

TOTAL
No

Correctly Stated Recommended Timeframe?
(up to 72 hours after unprotected sex)
82.1%
76.3%
63.3%

36.7%
23.7%
17.9%
URBAN

RURAL
Correct
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Incorrect

TOTAL

Correctly Stated that EC is not the Same as
Seeking an Abortion?
92.5%
84.2%
64.3%

36.7%
23.7%
7.5%
URBAN

RURAL
Correct

TOTAL

Incorrect

Average Perceived Discomfort Score
(Higher Number= More Discomfort)
2.29

1.71
1.43

URBAN

RURAL
Perceived Discomfort
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TOTAL

Average Perceived Judgemental Score
(Higher Number= More Judgemental)
2.23

1.67
1.43

URBAN

RURAL

TOTAL

Perceived Judgemental

Average Perceived Unhelpful Score
(Higher Number= More Unhelpful)
2.81
2.38
2.19

URBAN

RURAL
Perceived Unhelpful
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TOTAL

Average Perceived Negative Attitude Score
(Higher Number= More Negative)

2.44
1.92
1.69

URBAN

RURAL

TOTAL

Perceived Negative Attitude

Average Overall EC Knowledge Correct
Answers (Higher Number= More Answers
Correct)
3.63

3.40
2.87

URBAN

RURAL
Correct Answer Average
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TOTAL

Appendix III: Significant Differences/ Associations Between Chain and
Private Pharmacies

Does Pharmacy Stock EC?
87.0%

84.7%

50.9%

49.1%

13.0%
CHAIN

15.2%
PRIVATE
Yes

TOTAL

No

Had EC in Stock at Time of Call?

97.9%

92.8%

64.7%

35.3%
2.1%
CHAIN

7.2%
PRIVATE
Yes
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No

TOTAL

Need a Perscription to Purchase?

97.8%

95.1%
72.7%

27.3%
2.2%

4.9%
CHAIN

PRIVATE
Yes

TOTAL

No

Correctly Answered that Adult is Not
Required to Purchase?
70.0%

65.2%

62.4%

34.8%

CHAIN

37.6%
30.0%

PRIVATE
Correct

94

Incorrect

TOTAL

Correctly Stated that EC is not the Same as
Seeking an Abortion?
87.2%

84.2%

55.6%
44.4%

15.8%

12.8%
CHAIN

PRIVATE
Correct

TOTAL

Incorrect

Average Cost of EC
$43.51

$42.69
$36.05

CHAIN

PRIVATE
Average Price

95

TOTAL

Average Perceived Discomfort: Range 0-5
(Higher Number= More Discomfort)
2.73

1.71

1.59

CHAIN

PRIVATE

TOTAL

Perceived Discomfort

Average Perceived Negative Attitude: Range 0-5
(Higher Number= More Negative)
2.73

1.92

1.82

CHAIN

PRIVATE
Perceived Negative Attitude

96

TOTAL

Appendix IV: IRB Letter of Approval

97

Curriculum Vitae

Zona J Ascensio
1418 Clayton Ct | Bowling Green, KY 42104 | 270.303.0262 | zona.ascensio@barrenriverhealth.org

EDUCATION
MPH: Master of Public Health
Public Health Education and Promotion
Western Kentucky University; Bowling Green, KY; May 2017 (in progress)
Elective Coursework in Public Health Research including Advanced Biostatistics, Epidemiology,
and Research Methods
Thesis: “Pharmacy-Based Barriers to Adolescent Access to Over-the-Counter Emergency
Contraception in Kentucky”
Bachelor of Arts
Spanish and Liberal Arts: Medical Anthropology (double major)
Murray State University; Murray, KY; May 2014
Degree Honors: Summa cum Laude
Study Abroad: Yucatan, Mexico
Thesis: “Cross-Cultural Curing: The Role of Traditional Medicine in the Yucatan and What
Western Medicine Can Learn”

EMPLOYMENT AND PROFESSIONAL EXPERIENCE














Barren River District Health Department; Bowling Green, KY
August 2016-Present
Community Mobilization Coordinator
Facilitates and coordinates the BRIGHT Coalition and health department community outreach
endeavors
Develops branch and program-specific service plans with collaboration from program owners
Assists Planning, Quality and Communication team with BRIGHT Coalition meetings and Regional
Mobilizing for Action through Planning and Partnerships (MAPP) Process
Develops relationships with community agencies and the public to better identify shared goals
and areas for collaboration
Assists Community Health Planner and agency staff in developing grant applications
Works to develop formalized collaborative relationships with post-secondary institutions as
recommended by the Kentucky Department for Public Health and the Public Health Foundation
(Build Academic Health Department)
Participates fully in agency’s strategic planning, CHIP, CHA and Public Health Accreditation
processes.
Prepares reports and presentations as requested by staff and community partners
Assists with the development and implementation of marketing campaigns involving external
agencies
Identifies agency’s chain of command and management system for emergency response
Participates in Bioterrorism and Emergency Preparedness drills/exercises

98
















•
•








WKU: Department of Public Health; Bowling Green, KY
January 2015-Present
Graduate Assistant
Assists in teaching a senior-level undergraduate Women’s Health course: Monitors class
discussion boards, grades quizzes/exams, final paper and other assignments and records grades
in grade book; answers student questions and maintains course content on Blackboard
Translates surveys and documents into Spanish
Develops tables and charts, maps competencies, finds and downloads forms, and synthesizes
materials essential for the Council on Education for Public Health (CEPH) accreditation self-study
Developed electronic resource file for CEPH accreditation self-study
Assists faculty members with meetings, record keeping, and other miscellaneous projects
Uses SPSS to analyze surveys for various local health departments and faculty research
Synthesizes MPH admissions information into an Excel spreadsheet for future analysis
Develops surveys using Qualtrics survey software
Assists undergraduate and graduate students with independent writing projects (Honors theses;
masters capstones, etc.)
Writes press releases for the College of Health and Human Services and WKU News on behalf of
the Department of Public Health
Acts as webmaster to the Department of Public Health website
Murray State University: Psychology Department; Murray, KY
August 2013-August 2014
Student Office Associate
Aided the administrative assistant in meeting the various organizational needs of the department
while maintaining the required confidentiality
Copied, sorted and filed paperwork such as testing materials, student and clinical patient
records, and faculty application packages
Searched for books, journal articles, or other educational materials for professors and the
administrative assistant upon request.
Performed routine clerical functions
Proctored exams and assisted faculty with class-related activities as needed
Yahoo! News and Contributor Network/ Demand Media; Online
January 2010- May 2013
Freelance Journalist
Wrote feature articles, bulletins, sales letters, and other related informative, marketing and
promotional material
Conducted research to obtain factual information and authentic detail, using internet research as
well as reviewing newspaper accounts, diaries, and interviews
Named as one of the top contributors for 2012 and 2013
Named featured contributor in the green living, entertainment, and lifestyle categories

RESEARCH AND REPORTS
Ascensio, Zona J. Pharmacy-Based Barriers to adolescent Access to Over-the-Counter Emergency
Contraception in Kentucky (Graduate Thesis; Western Kentucky University, 2017)
Ascensio, Zona J. and Shearer, Darlene S. As Long as I’m Not Hurting Anyone Else: Perceived
Personal Threat versus Altruistic Motivations for Smoking Cessation in Todd County, Kentucky
(Independent Study in Community Health Term Paper; Ongoing Research: Western Kentucky
University, 2016)

99

Ascensio, Zona J and Farrell, Colin T. The Effect of Exposure to Prison Violence on Factors
Predicting Recidivism (Advanced Biostatistics Term Paper; Ongoing Research: Western Kentucky
University, 2016)
Shearer, Darlene S. and Ascensio, Zona J. Analysis of Responses to the 2015 Community- Wide
Survey Submitted to the BRIGHT Coalition (Report to the Barren River Initiative to Get Healthy
Together (BRIGHT) coalition and Barren River District Health Department: Western Kentucky
University, 2015)
Ascensio, Zona J. From Ethnography to Magical Realism: Fathoming other Worldviews through
Literature (Spanish Senior Capstone: Murray State University, 2014)
Ascensio, Zona J. Cross-Cultural Curing: The Role of Traditional Medicine in the Yucatan and what
Western Medicine Can Learn (Undergraduate Thesis: Murray State University, 2013)

PROFESSIONAL PRESENTATIONS
“Pharmacy-Based Barriers to Adolescent Access to Over-the-Counter Emergency Contraception in
Kentucky” at the Kentucky Public Health Association Conference (April 12, 2017)
“Pharmacy-Based Barriers to Adolescent Access to Over-the-Counter Emergency Contraception in
Kentucky” at the Western Kentucky University Student Research Conference (March 25, 2017)
“No Such Thing as Safe Secondhand Smoke in Todd County, KY” at the Kentucky Public Health
Association Conference (April 12, 2016)
“The Effect of Family Participation in Traditional Culture on American Indian and Alaska Native
Youth Suicide Risk” at the Western Kentucky University Student Research Conference (March 28,
2015)
“From Ethnography to Magical Realism: Fathoming other Worldviews through Literature” at the
Murray State University Scholars Week (April 15, 2014)
“Tour of a Traditional Mayan Pharmacy in Yucatan Mexico” at the Murray State University
Liberal Arts Research Forum (November 20, 2013)

AWARDS AND HONORS








Outstanding College of Health and Human Services Graduate Student: Awarded for outstanding
academic performance and service to the College of Health and Human Services and to the
Department of Public Health. One of 7 graduate award recipients specifically recognized at the
2017 commencement ceremony (April, 2017).
Academic Excellence in Master of Public Health: Awarded by Western Kentucky University’s
Department of Public Health for overall academic achievement in the Master of Public Health
program during the College of Health and Human Services annual awards banquet (April, 2017).
College of Health and Human Services Graduate Tuition Scholarship: Awarded by Western
Kentucky University’s College of Health and Human Services for academic prowess, peer
mentorship, and commitment to the public health profession (May, 2016).
Outstanding Service Award: Recognized for exceptional service to the Department of Public
Health during the College of Health and Human Services awards banquet at Western Kentucky
University (April, 2016).

100









Dedicated Service Award: Recognized for outstanding service to the WKU chapter of the
Kentucky Public Health Association during the KPHA awards breakfast (April, 2016).
Outstanding Spanish Student: Recognized for overall academic achievement in the Spanish
major during the Honors Day ceremony at Murray State University (May, 2014).
Outstanding Service Award: Recognized for exceptional service to the International Cultures and
Languages Association during the Department of Modern Languages’ Year End Banquet at
Murray State University (May, 2014).
Outstanding Senior in Spanish: Recognized for academic accomplishments in Spanish during the
senior year during the Department of Modern Languages’ Year End Banquet at Murray State
University (May, 2014).
International Travel Grant: Awarded by the Murray State University College of Humanities and
Fine Arts for study abroad in Merida, Yucatan, Mexico (November, 2012).

OUTREACH AND VOLUNTEER ACTIVITIES


Public Health Undergraduate-Graduate Associated Students (PHUGAS) (October 2016Present) Co-founder of an organization that serves as a medium for student
representation and engagement in the shared governance of Western Kentucky
University’s Public Health Programs (BSPH and MPH).



Graduate Representative to the CEPH Transition Steering Committee (November 2016Present) Voting member on committee to facilitate WKU’s Public Health Program’s
transition to new accreditation criteria.



Graduate Representative to the Public Health Program Committee (October 2016Present) Voting member on committee for both the Bachelor of Public Health and
Master of Public Health programs.



Kentucky Public Health Assistance and Support Teams (K-PHAST) training (September
2016- January 2017) Assisted with program coordination by acting as liaison to the
Barren River District Health Department’s Epidemiology Rapid Response Team, to
WKU’s Public Health Faculty, and to the Public Health student body to bring this training
to WKU for the first time.



Student Representative to the Building Epidemiology Capacity in Kentucky (BECKY)
project (Fall 2016) Attended teleconferences and annual BECKY conference on behalf of
WKU’s Public Health student body.



International Education Week: The Bigger Picture of Global Public Health (Fall 2016)
Planned, coordinated, headed recruitment for major departmental event focusing on
global health issues on behalf of WKU’s Department of Public Health.



Student Representative to the MPH Curriculum Committee (May 2015- May 2016):
Confidentially brings student concerns to the MPH faculty and contributes to processes
relating to accreditation and the program in general.



Progressive Agricultural Safety Day (September 2015): Developed, directed and
participated in short role-playing scenarios to teach 600 local fourth graders about
internet safety on behalf of KPHA.



International Education Week: Public Health in a Global World Planning Committee
(Fall 2015): Worked with representatives from Western Kentucky University’s

101

Department of Public Health to plan and implement a new event to promote awareness
of public health issues around the world.


Chinese New Year/Mardi Gras Planning Committee (Fall 2013-Spring 2014): Met with
representatives from Murray State University’s Food Services and from the Department
of Modern Languages to plan two major joint events for Chinese New Year and Mardi
Gras.



ESL Conversation Partner (Fall 2013-Spring 2014): Met weekly with small groups of
international students to help strengthen their English speaking skills.



Campus International Ambassador (Fall 2013): Welcomed new international students
to campus, planned events and outings to introduce them to the area, and assisted
them as necessary.



Campus Safe Zone Participant (Fall 2013-Fall 2014): Attended trainings to better
understand LGBTQ issues and how to sensitively address the various needs of this
community on campus.

ORGANIZATIONS


Public Health Undergraduate-Graduate Associated Students (PHUGAS): Fall 2016Present
o President: Spring 2017
o Vice President: Fall 2016



Kentucky Public Health Association: Spring 2015- Present
o Historian/ Social Media Coordinator: Summer 2015-Fall 2016



International Cultures and Languages Association: Spring 2012- Fall 2014
o Vice president: Fall 2013-Fall 2014





Alpha Mu Gamma Foreign Language Honor Society: Fall 2013- Present
Lambda Alpha Anthropology Honor Society: Spring 2013- Present
Phi Kappa Phi National Honor Society: Spring 2013- Present

TECHNOLOGY SKILLS








Word processing and Spreadsheets: Microsoft Word, Microsoft Excel, Google Docs,
Google Spreadsheets
Statistical Software: SPSS, SAS
Survey Software: Qualtrics, Survey Monkey
Database management: Microsoft Access
Webpage Design: OU Campus, Microsoft FrontPage
Graphic Design: Adobe Photoshop, Microsoft Publisher
Other skills: Knowledge of and experience with HTML, XML, Search Engine Optimization
(SEO), Klipfolio, and Google Analytics

102

References
American Society for Emergency Contraception. (2013, July). Emergency Contraception.
Retrieved from Princeton University:
http://ec.princeton.edu/ASECPricingReport.pdf

American Society for Emergency Contraception. (2014, April). EC ON THE SHELF:
Real-World Access in the OTC Era. Retrieved from American Society for
Emergency Contraception:
http://americansocietyforec.org/uploads/3/2/7/0/3270267/asec_ec_access_report.p
df

Atkins, D. N., & Bradford, W. D. (2015). Association between increased emergency
contraception availability and risky sexual practices. Health services
research, 50(3), 809-829.

Baird, D. T., Cameron, S., Evers, J. L. H., Gemzell-Danielsson, K., Glasier, A., Moreau,
C., & Volpe, A. (2015). Emergency contraception. Widely available and effective
but disappointing as a public health intervention: a review. Human Reproduction,
dev019.

Batra, P., Aquilino, M. L., & Farris, K. B. (2015). Pharmacy staff perceptions and selfreported behaviors related to providing contraceptive information and counseling.
Journal of the American Pharmacists Association: JAPhA, 55(5).

Bell, D. L., Camacho, E. J., & Velasquez, A. B. (2014). Male access to emergency
contraception in pharmacies: a mystery shopper survey. Contraception, 90(4),
413-415.

Cleland, Kelly, Raymond, E. G., Westley, Elizabeth, & Trussell, James. (2014).
Emergency contraception review: evidence-based recommendations for
clinicians. Clinical obstetrics and gynecology, 57(4), 741-750.

Clotter, J. C. (2000). Our Kentucky: A Study of the Bluegrass State. Lexington:
University Press of Kentucky.
103

Craig, A., Dehlendorf, C., Borrero, S., Harper, C., & Rocca, C. (2014). Exploring Young
Adults' Contraceptive Knowledge and Attitudes: Diaparities by Race/Ethnicity
and Age. Women's Health, e281-e289.

Devine, K. S. (2012). The underutilization of emergency contraception. AJN The
American Journal of Nursing, 112(4), 44-50.

Dehlendorf, C., Rodriguez, M., Levy, K., Borrero, S., & Steinauer, J. (2010). Disparities
in Family Planning. American Journal of Obstetrics and Gynecology, 214-220.
Retrieved from
http://www.sciencedirect.com.libsrv.wku.edu/science/article/pii/S0002937809009
478

Durrance, C. P. (2013). The effects of increased access to emergency contraception on
sexually transmitted disease and abortion rates. Economic Inquiry, 51(3), 16821695.

Fallon, D. (2010). Accessing emergency contraception: the role of friends in the
adolescent experience. Sociology of health & illness, 32(5), 677-694.

Finer, L., & Zolna, M. (2011). Unintended pregnancy in the United States: Incidence and
disparities, 2006. Contraception, 478-485. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338192/

Foster, D. G., Biggs, M. A., Phillips, K. A., Grindlay, K., & Grossman, D. (2015).
Potential public sector cost-savings from over-the-counter access to oral
contraceptives. Contraception, 91(5), 373-379.

Frost, J. (2011). The state of hormonal contraception today: overview of unintended
pregnancy . American Journal of Obstetrics and Gynecology, S1-S3. Retrieved
from
http://www.sciencedirect.com.libsrv.wku.edu/science/article/pii/S0002937811008
040

104

Gaffaney, M., Stamm, C., Borgelt, L., Chau, V. M., Rupp, L., Blumhagen, R., & Gilroy,
C. (2015). 67. Barriers to Emergency Contraception Access in the State of
Wyoming. Journal of Adolescent Health, 56(2), S36

Gemzell-Danielsson, K., Berger, C., & Lalitkumar, P. G. L. (2013). Emergency
contraception—mechanisms of action. Contraception, 87(3), 300-308.

Glasier, A. (2013). Emergency contraception: clinical outcomes. Contraception, 87(3),
309-313.

Gross, T., Lafortune, J., & Low, C. (2014). What happens the morning after? The costs
and benefits of expanding access to emergency contraception. Journal of Policy
Analysis and Management, 33(1), 70-93.

Guttmacher Institute. (2016a, March). Unintended Pregnancy in the United States.
Retrieved from Guttmacher Institute website:
https://www.guttmacher.org/sites/default/files/factsheet/fb-unintended-pregnancyus_0.pdf
Guttmacher Institute. (2016b, May 1). Protecting Confidentiality for Individuals Insured
as Dependents. Retrieved from Guttmacher Institute:
https://www.guttmacher.org/sites/default/files/state_policy_overview_files/spib_c
mii.pdf

Guttmacher Institute. (2016c, May 1). Minors' Access to Contraceptive Services.
Retrieved from Guttmacher Institute: https://www.guttmacher.org/statepolicy/explore/minors-access-contraceptive-services

Guttmacher Institute. (2016d, April). American Teens' Sources of Sexual Health
Education. Retrieved from Guttmacher Institute:
https://www.guttmacher.org/sites/default/files/factsheet/american-teens-sourcesof-sexual-health-education_0.pdf

Iowa State University. (2017). Urban Percentage of the Population for States, Historical.
Retrieved from http://www.icip.iastate.edu:
http://www.icip.iastate.edu/tables/population/urban-pct-states
105

Kaiser Family Foundation. (2016, August). Emergency Contraception. Retrieved from
Kaiser Family Foundation: http://files.kff.org/attachment/emergencycontraception-fact-sheet

Kelleher, J. (2010). Emergency contraception and conscientious objection. Journal of
Applied Philosophy, 27(3), 290-304.

Kentucky Cabinet for Health and Family Services. (2015). Family Planning. Retrieved
from http://chfs.ky.gov: http://chfs.ky.gov/dph/info/dwh/birthcontrol.htm

Kost, K. (2015, January). Unintended Pregnancy Rates at the State Level: Estimates for
2010 and Trends Since 2002. Retrieved from Guttmacher Institute:
https://www.guttmacher.org/sites/default/files/report_pdf/stateup10.pdf

Koyama, A., Hagopian, L., & Linden, J. (2013). Emerging options for emergency
contraception. Clinical medicine insight: Reproductive health, 7, 23-35.

Legare, K., Bakshi, S., Keyhani, S., & Howell, E. A. (2012). Availability of over-thecounter emergency contraception in 2 disparate New York City
neighborhoods. American journal of public health, 102(11), e45-e47.

Lewis, J. D., & Sullivan, D. M. (2012). Abortifacient potential of emergency
contraceptives. Ethics & Medicine, 28(3), 113.

Mackin, M. L., & Clark, K. (2011). Emergency Contraception in Iowa Pharmacies
Before and After Over‐the‐Counter Approval. Public Health Nursing, 28(4), 317324.

Manski, R., & Kottke, M. (2015). A survey of teenagers’ attitudes toward moving oral
contraceptives over the counter. Perspectives on sexual and reproductive
health, 47(3), 123-129.

106

Melton, L., Stanford, J. B., & Dewitt, M. J. (2012). Use of Levonorgestrel Emergency
Contraception In Utah: Is It More than “Plan B”?. Perspectives on sexual and
reproductive health, 44(1), 22-29.

Mollen, C. J., Miller, M. K., Hayes, K. L., & Barg, F. K. (2013). Knowledge, attitudes,
and beliefs about emergency contraception: a survey of female adolescents
seeking care in the emergency department. Pediatric emergency care, 29(4), 469474.

Orr, K. K., Lemay, V. A., Wojtusik, A. P., Opydo-Rossoni, M., & Cohen, L. B. (2015).
Availability and accuracy of information regarding nonprescription emergency
contraception. Journal of pharmacy practice, 0897190014568378. Retrieved from
PubMed: http://www http://www.ncbi.nlm.nih.gov/pubmed/25637393#

Price, K. (2011). The quest for purity: The role of policy narratives in determining teen
girls’ access to emergency contraception in the USA. Sexuality Research and
Social Policy, 8(4), 282-293.

Rafie, S., McIntosh, J., Gardner, D. K., Gawronski, K. M., Karaoui, L. R., Koepf, E. R.,
... & Patel‐Shori, N. M. (2013). Over‐the‐Counter Access to Emergency
Contraception without Age Restriction: An Opinion of the Women's Health
Practice and Research Network of the American College of Clinical
Pharmacy. Pharmacotherapy: The Journal of Human Pharmacology and Drug
Therapy, 33(5), 549-557.

Ragland, D., Payakachat, N., & Stafford, R. A. (2015). Emergency Contraception
Counseling in a Retail Pharmacy Setting A Pilot Study. Journal of pharmacy
practice, 28(3), 261-265.

Raine, T. R., Ricciotti, N., Sokoloff, A., Brown, B. A., Hummel, A., & Harper, C. C.
(2012). An over-the-counter simulation study of a single-tablet emergency
contraceptive in young females. Obstetrics & Gynecology, 119(4), 772-779.

Richard, C. A., Kinzey, H., & Masters, K. (2015). Pharmacists’ Attitudes towards Three
Models of Expanded Access to Hormonal Contraception in
Pharmacies. International Journal, 3(1), 5-16.
107

Richman, A. R., Daley, E. M., Baldwin, J., Kromrey, J., O'Rourke, K., & Perrin, K.
(2012). The role of pharmacists and emergency contraception: are pharmacists'
perceptions of emergency contraception predictive of their dispensing
practices? Contraception, 86(4), 370-375.

Samson, F. D., Loren, R., Downing, N., Schroeppel, S., Kelly, P. J., & Ramaswamy, M.
(2013). Availability of Emergency Contraception in Rural and Urban Pharmacies
in Kansas. The Journal of Rural Health, 29(1), 113-118.

Schrager, S. M., Olson, J., Beharry, M., Belzer, M., Goldsich, K., Desai, M., & Clark, L.
F. (2014). Young men and the morning after: a missed opportunity for emergency
contraception provision? Journal of Family Planning and Reproductive Health
Care, jfprhc-2013.

Stacey, D. (2014, March 10). The History of Emergency Contraception. Retrieved from
verywell: https://www.verywell.com/the-history-of-emergency-contraception906714

Stanger-Hall, K., & Hall, D. (2011). Abstinence-Only Education and Teen Pregnancy
Rates: Why We Need Comprehensive Sex Education in the U.S. PLoS ONE, n.a.
Retrieved from
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0024658

Thompson, K. M., Raine, T. R., Foster, D. G., Speidel, J. J., Darney, P. D., Brindis, C.
D., & Harper, C. C. (2013). Access to levonorgestrel emergency contraception:
science versus federal politics. Women's Health, 9(2), 139-143.

University of Wisconsin Population Health Institute. (2016). Kentucky Overview.
Retrieved from County Health Rankings and Roadmaps:
http://www.countyhealthrankings.org/app/kentucky/2016/overview

U.S. Department of Health and Human Services. (2016). Public Health 3.0: A Call to
Action to Create a 21st Century Public Health Infrastructure. Washington D.C.:
Office of the Assistant Secretary for Health.
108

U.S. Department of Health and Human Services. (2016, Feburary 2). Emergency
Contraception. Retrieved from U.S. Department of Health and Human Services:
https://www.hhs.gov/opa/pregnancy-prevention/hormonal-methods/emergencycontraception/index.html

U.S. Department of Health and Human Services. (2016). Kentucky Reproductive Health
Facts. Retrieved from: http://www.hhs.gov/ash/oah/adolescent-healthtopics/reproductive-health/fact-sheets/state.html?s=kentucky

U.S. Department of Health and Human Services. (2015, September 15). Kentucky
Reproductive Health Facts. Retrieved from U.S. Department of Health and
Human Services: http://www.hhs.gov/ash/oah/adolescent-healthtopics/reproductive-health/fact-sheets/state.html?s=kentucky

U.S. Department of Health & Human Services. (2014). Family Planning. Retrieved from
Healthy People website: https://www.healthypeople.gov/2020/topicsobjectives/topic/family-planning/objectives

Wilkinson, T. A., Fahey, N., Shields, C., Suther, E., Cabral, H. J., & Silverstein, M.
(2012). Pharmacy communication to adolescents and their physicians regarding
access to emergency contraception. Pediatrics, 129(4), 624-629.

Wilkinson, T. A., Vargas, G., Fahey, N., Suther, E., & Silverstein, M. (2014). “I'll See
What I Can Do”: What Adolescents Experience When Requesting Emergency
Contraception. Journal of Adolescent Health, 54(1), 14-19.

Yen, S., Parmar, D. D., Lin, E. L., & Ammerman, S. (2015). Emergency contraception
pill awareness and knowledge in uninsured adolescents: high rates of
misconceptions concerning indications for use, side effects, and access. Journal of
pediatric and adolescent gynecology, 28(5), 337-342.

Young, S., Griffin, B., & Vest, K. (2013). Active-learning instruction on emergency
contraception counseling. American journal of pharmaceutical education, 77(5).

109

